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 Epidemiological and animal studies firmly establish that nutritional and 
environmental exposures during early embryonic development play a critical role in adult disease 
susceptibility, such as obesity, type 2 diabetes, and neurodevelopmental disorders. Epigenetic 
reprogramming is a molecular consequence of exposures during critical developmental periods. 
Linking environmental exposures to adult disease via epigenetic mechanisms may help our 
understanding of human complex disease prevention, diagnosis, and treatment.  
 Bisphenol A (BPA), a high production-volume chemical monomer used in 
polycarbonate plastic and epoxy resins, is found in consumer products including food and water 
containers, receipts, baby bottles, and metal can linings. Due to its ubiquitous presence in the 
environment and ability to leach from consumer products, humans are continuously exposed to 
BPA.  Thus, several studies have measured detectable levels of BPA in urine, breast milk, and 
placental tissue in populations around the world including the United States, Korea, and China. 
 This dissertation develops and utilizes a dose-dependent mouse model of multiple 
human physiologically relevant levels of BPA exposure (50 ng, 50 g, and 50 mg BPA/kg diet) 
in utero and during lactation, and evaluates BPA’s influence on offspring metabolic parameters 
throughout the life-course, hormonal status at 9 and 10 months, and epigenetic gene regulation at 
post-natal day 22 and 10 months. First, perinatal BPA exposure was associated with several 
metabolic phenotypes at 3, 6, and 9 months of age, including increased spontaneous activity, 




were more prominent in female, rather than male offspring. Additionally, females at the highest 
exposure dose displayed an increase in insulin sensitivity, increased adiponectin levels, and 
decreased leptin levels. Thus, life-course analysis illustrates that perinatal BPA exposure is 
associated with hyperactive and lean phenotypes. 
 Second, developmental BPA exposure was linked to alterations to the epigenome in 
early life (postnatal day 22), including global DNA methylation levels as well as candidate gene 
methylation levels at two well-characterized metastable epialleles and five additional genes 
linked to metabolic homeostasis. Specifically, global DNA methylation among CCGG site 
throughout the genome were significantly decreased in all BPA exposure groups. Offspring 
exposed to the highest BPA exposure dose displayed hypomethylation at the A
vy
 locus. Offspring 
exposed to the middle BPA exposure dose displayed hyper- and hypomethylation at Cabp
IAP
 and 
H19, respectively. Finally, offspring exposed to the high and low exposure doses displayed 
hypermethylation at Igf2. These epigenetic data suggest that developmental BPA exposure 
through the maternal diet is altering normal levels as compared to controls of DNA methylation 
in candidate genes, as well as globally in PND 22 tissue, and may program individuals for later 
in life disease susceptibility. 
 Lastly, an epigenome-wide discovery platform was utilized to elucidate epigenetic 
alterations in adult offspring (10 months of age) following perinatal BPA exposure. Biological 
pathway analysis was run on the significant differentially methylated regions among females to 
determine enriched pathways that may be involved in the metabolic or hyperactive phenotypes 
displayed in the BPA exposed offspring from the metabolic phenotyping. Furthermore, utilizing 
the top enriched biological pathways, three candidate genes were chosen to assess DNA 




metabolic life-course analysis. DNA methylation in two top hit candidate genes, Irs-2 and Jak-2, 
was linked as a potential mediator in the mechanistic pathways in BPA exposed females and the 
adiponectin and glucose phenotypes, respectively.  
 In summary, this project illustrates that perinatal BPA exposure is associated with 
hyperactive and lean murine phenotypes mediated by alterations to normal DNA methylation 
patterns. Data generated from this study is crucial for deciphering the role of epigenetics in the 
pathogenesis of chronic disease and the development of novel epigenetic-based prevention and 



















CHAPTER 1  
Introduction 
1.1  Overview of Dissertation  
 The overall theme of this dissertation is the role of early life chemical and nutritional 
exposures on the susceptibility of disease formation in adulthood. A growing body of work 
supports the developmental origins of health and disease (DOHaD) hypothesis, in which 
environmental insults early in development influence chronic disease outcomes such as obesity, 
type 2 diabetes, cancer, and cardiovascular disease later in life [Barker, 2004; Bateson et al., 
2004]. The mechanistic link between what individuals are exposed to in early life and disease 
formation throughout the life-course appears to involve alterations to epigenetic modifications 
such as DNA methylation at labile loci. Epigenetics is the study of mitotically heritable yet 
potentially reversible, molecular modifications to DNA and chromatin without alteration to the 
underlying DNA sequence [Li, 2002; Reik et al., 2001]. Though DNA sequence is fairly 
permanent, epigenetic modifications are dynamic throughout the life-course and can be heavily 
influenced by external factors [Reik et al., 2001]. Thus, external effects on the epigenome may 
alter gene expression, potentially giving rise to phenotypic disparity including disease formation.  
 The objective of this dissertation project is to further understand the role of perinatal 
(gestational and lactational) exposure to multiple physiologically relevant levels of the high 
production chemical bisphenol A (BPA) on the development of metabolic disease throughout the 




developmental BPA exposure. Furthermore, it is of importance to strengthen our understanding 
of the biological pathways associated with developmental insults and adult disease formation by 
elucidating whether epigenetic mechanisms are mediating these relationships. 
 
1.2  Background 
 
1.2.1  Bisphenol A 
 Bisphenol A (BPA) is a monomer produced in high volumes and comprises 
polycarbonate plastics and epoxy resins. It is found in consumer products such as food and 
beverage containers, baby bottles, dental composites, thermal paper, and the inside lining of 
metal cans.  BPA can leach from these consumer products under high temperature, acidic or 
basic conditions, presenting many opportunities for human exposure, most commonly via 
ingestion, and also to a lesser extent via inhalation and dermal routes [Vandenberg et al., 2010]. 
Thus, BPA is of health concern because it is ubiquitous in the environment resulting in 
widespread human exposure. Several studies have reported detectable levels of total urinary BPA 
in a majority of individuals in populations around the world, including the United States, China, 
Japan, and Korea [Calafat et al., 2008; Zhang et al., 2011].  
BPA can mimic or antagonize endogenous hormones, and subsequently perturb 
endocrine function [Gould et al., 1998; Kuiper et al., 1998]. BPA has been most widely studied 
as an environmental estrogen and has binding affinities for estrogen receptors alpha and beta (ER 
α and β), G protein-coupled receptor 30 (GPR30), and estrogen related receptor gamma (ERR γ) 
[Thomas et al., 2006]. Dependent upon the dose, cell type, and ER isoform, BPA can exert 




interfere with thyroid and androgen receptor activity [Kruger et al., 2008; Moriyama et al., 
2002]. BPA can activate transcription factors, such as peroxisome proliferator-activated 
receptors (PPARs) and the aryl hydrocarbon receptor (AhR) [Kruger et al., 2008; Sui et al., 
2012]. Because these receptor pathways play an important role in gene regulation, BPA may 
influence normal differentiation and maturation processes during embryonic and fetal 
development, predisposing individuals to chronic disease development such as obesity, type 2 
diabetes, and metabolic syndrome throughout the life-course [Bateson et al., 2004].   
 
1.2.2  Bisphenol A, Obesity, and Metabolic Disorders 
The dramatic rise in obesity over the last few decades has led scientists to look beyond 
excessive calorie intake and lack of physical activity as the main contributing factors [Holtcamp, 
2012]. Concurrently, over the past several decades developmental environmental insults, 
including BPA exposure, have exhibited the ability to perturb the metabolic signaling that play 
key roles in adipose tissue biology and the homeostatic control of appetite and satiety [MacKay 
et al., 2013]. Consequently, these environmental insults resulting in long lasting obesity 
phenotypes have been labeled as obesogens [Blumberg et al., 2011; Grün et al., 2006].  
Increasingly animal studies indicate that BPA can disrupt metabolic homeostasis by 
interfering with endocrine hormone pathways such as thyroid, estrogen, and androgen receptors 
resulting in a variety of metabolic disorders [Alonso-Magdalena et al., 2008; Moriyama et al., 
2002; Rubin et al., 2009]. For example, BPA administered subcutaneously in 8 week old male 
mice was associated with hyperinsulinemia without a change in blood glucose demonstrating a 
classic indication of insulin resistance [Alonso-Magdalena et al., 2006]. Furthermore, the female 




decreased insulin sensitivity at 6 months of age, both signs of type 2 diabetes [Alonso-
Magdalena et al., 2010]. Perinatal BPA exposure has also been associated with overexpression of 
lipogenic genes such as CAAT enhancer binding protein alpha, peroxisome proliferator-activated 
receptor gamma (PPAR-γ), and lipoprotein lipase leading to enhanced adipogenesis [Somm et 
al., 2009]. Peri- and postnatal BPA exposure has resulted in an increase in body weight due to 
increased adipose tissue mass accompanied by increased total cholesterol and triacylglycerol 
[Miyawaki et al., 2007; Somm et al., 2009]. PPAR- γ is a key regulator in adipose cell 
differentiation [Tontonoz et al., 2008].  In vitro studies reveal enhanced expression of PPAR- γ 
in 3T3-L1 pre-adipocytes promoting increased production of adipocytes [Sargis et al., 2010]. In 
human subcutaneous and visceral adipose tissue explants, BPA not only inhibited the release of 
adiponectin but also stimulated the release of inflammatory adipokines interleukin-6 and tumor 
necrosis factor α, common inflammatory markers found in overweight or obese individuals [Ben-
Jonathan et al., 2009; Hugo et al., 2008].  
Alternatively, there have been reports on developmental BPA exposure and metabolic 
endpoints that exhibit null results or outcomes that produce weight loss. For example, rats 
exposed to 2.5 or 5 µg BPA/kg body weight per day from GD 6 through PND 21 had 
significantly lower body weights compared to controls from PNDs 0 to 21 [Ferguson et al., 
2011]. Also, using repeated body weight measurements, CD-1 mice exposed to dietary BPA 
during gestation and lactation were heavier than controls at 4 weeks of age, but this association 
was diminished in adulthood, and the effect did not persist in offspring fed a high fat diet [Ryan 
et al., 2010]. 
Although human epidemiological studies have shown associations among BPA exposure 




example, in children aged 8-11 years of age, obesity was positively associated with increasing 
urinary levels of BPA [Wang et al., 2012]. In adults 40  years of age or older, increasing levels of 
urinary BPA were associated with abdominal obesity and insulin resistance [Wang et al., 2012]. 
A positive association was found between BPA urinary levels and type 2 diabetes and 
cardiovascular disease in adult participants of the 2003-04 NHANES [Lang et al., 2008] as well 
as with coronary heart disease in adult participants of the 2005-06 NHANES [Melzer et al., 
2010]. One epidemiological study of longitudinal design demonstrated that urinary BPA levels at 
5 years of age was positively associated with body mass index (BMI) at 9 years of age in boys, 
while prenatal BPA exposure was positively associated with BMI in girls 9 years of age. [Harley, 
2013]. Studies of this nature are time-consuming and require long standing cohorts, thus, well-
established cohorts are lacking that measure BPA prenatally and follow the children throughout 
the life-span.  
 
1.2.3  Bisphenol A and Hyperactivity 
Despite the increasing evidence describing BPA as an obesogen, another proposed target 
of BPA involves impairment of central nervous system development [Masuo et al., 2011]. The 
prevalence of neurodevelopmental disorders like Attention-Deficit and Hyperactivity Disorder 
(ADHD) and Autism Spectrum Disorder has consistently increased over the past few decades.  
Although the casual factors involved in the etiology of these disorders is not well understood, 
environmental exposures like BPA are being explored as contributing factors because of their 
ability to interfere with neuroendocrine systems during early development [de Cock et al., 2012; 




Animal studies of perinatal BPA exposure have shown outcomes that include increased 
spontaneous activity, aggression, anxiety, and altered cognitive function [Braun et al., 2011; 
Kundakovic et al., 2011]. For example, male mice that were exposed to 0.32 and 0.48 mg/ml 
BPA at PND 10 exhibited hyperactivity at 2 and 5 months of age [Viberg et al., 2011]. 
Additionally, male rats exposed to 87 nM BPA at PND 5 displayed hyperactivity compared to 
their control counterparts measured at 4-5 weeks of age [Ishido et al., 2011]. Finally, perinatal 
exposure to 2 µg/kg body weight of BPA in male rats was associated with hyperactivity and 
behavior linked with decreased attention [Zhou et al., 2011]. These animal studies that have 
demonstrated early developmental BPA exposure resulting in behavioral outcomes have been 
correlated to human clinical disorders such as ADHD and aggression [Ishido et al., 2004; 
Matsuda et al., 2010]. Animal models extended to testing both sexes are needed given the 
evidence that humans maternal BPA exposure is associated with aggression and increased 
activity among girls [Braun et al., 2009; Zhou et al., 2011]. 
The mechanistic action on BPA and resulting hyperactive phenotypes is still under 
investigation, but studies have pointed to the effects of BPA on the dopamergenic system.  In 
male mice exposed perinatally to 2 mg BPA/g of food showed a decrease in dopamine D3 
receptor density in the limbic forebrain [Mizuo et al., 2004]. The volume and density of tyrosine 
hydroxylase neurons, an important rate limiting enzyme in dopamine synthesis, was decreased in 
the substantia nigra after perinatal exposure to 3 µg BPA/g of food when measured at 11 weeks 
of age [Tando et al., 2007]. Lastly in male mice exposed to 20 µg/kg BPA perinatally, dopamine 
levels increased in certain brain regions [Nakamura et al., 2010]. The majority of these 
mechanistic studies have been limited to male animals, yet the behavioral outcomes are sexually 





1.2.4   Bisphenol A and Sexually Dimorphic Traits 
As emphasized above, it is important to explore these hyperactive and other behavioral 
phenotypes and mechanisms in both genders. During early development BPA can affect the 
development of sexually dimorphic areas of the brain [Wolstenholme et al., 2011]. For example, 
in rats exposed to BPA on PND 2, males displayed a significant increase of tyrosine hydroxylase 
containing neurons in the anteroventral periventricular nucleus of the hypothalamus resulting in 
neuron levels comparable to females [Patisaul et al., 2006]. Normally females have more 
tyrosine hydroxylase cells than males. Sex differences in certain brain regions emerge during late 
gestation and the early post-natal period in rodents and depend on the estrogen and androgen 
availability. Since BPA can interfere with estrogen and androgen receptors, it has the potential to 
interfere with the development of these regions resulting in sex-specific health outcomes 
[Patisaul et al., 2008].  
 
1.2.5  Epigenetics as a Mechanism Linking Bisphenol A Exposure and Health 
The developmental origins of health and disease (DOHaD) hypothesis postulates that 
chemical and/or nutritional exposures during prenatal and early postnatal development influence 
developmental plasticity, thereby altering susceptibility to adult chronic diseases. These long-
term adverse health outcomes due to environmental exposures during development can alter gene 
expression and affect phenotype by modifying the epigenome [Waterland et al., 2004]. 
Epigenetics literally means “above the genome,” and comprises the heritable changes in gene 
expression that occur in the absence of changes to the DNA sequence itself, including chromatin 




modifications of histone tails, and DNA methylation. Epigenetic marks are generally stable in 
somatic cells, however, during gametogenesis and early pre-implantation the epigenome 
undergoes extensive reprogramming with the purpose of establishing cell- and tissue-specific 
gene expression [Hajkova et al., 2002; Reik et al., 2001]. Metastable epialleles are of particular 
interest during epigenetic reprogramming due to their increased lability to environmental 
exposures. Once epigenetic marks are established, metastable epialleles, as well as imprinted 
genes, are generally very stable throughout the life-course. [Dolinoy et al., 2007 ; Waterland et 
al., 2006; Waterland et al., 2003; Waterland et al., 2006].  
Of these epigenetic modifications, DNA methylation is the best studied and 
characterized.  Methylation of DNA occurs when DNA methyltransferases (DNMTs) covalently 
attach methyl groups from S-adenosyl methionine to the carbon-5 position of cytosine bases, 
generating 5-methylcytosine. In mammals, DNA methylation is primarily a stable repressive 
mark found in CpG dinucleotides, however its regulation is more dynamic than previously 
believed [Maunakea et al., 2010]. For example, the epigenome is particularly dynamic during 
embryogenesis because of extensive DNA synthesis, and the elaborate DNA methylation 
patterning required for normal tissue development is established during early development, thus 
making methylation especially susceptible to environmental insults such as BPA [Faulk et al., 
2011] 
The effects on BPA exposure and DNA methylation have been mostly limited to 
candidate gene approaches in rodent models. For example, gestational exposure to 5 mg/kg BPA 
in mice was associated with hypomethylation in CpG sites in the Hoxa10 promoter region in 
female offspring [Bromer et al., 2010].  In rats, hypomethylation was observed at the nucleosome 




promoter following early neonatal exposure to 10 µg BPA/kg BW/day [Tang et al., 2012]. 
Additionally, exposure to BPA at 50 mg/kg diet during gestation and lactation has been shown to 




 [Dolinoy et al., 2007 ].  A 
limited number of studies have tried to link epigenetic modifications as the mechanism 
mediating BPA exposure and its association with disease phenotype. One study explored 
exposure to 10 µg BPA/kg BW/day in male rats during the neonatal period. This exposure 
resulted in hypomethylation at the phosphodiesterase type 4 variant 4 gene in prostate cancer 
cells and was associated with pre-neoplastic prostatic lesions during adulthood implicating that 
BPA has role in prostate cancer development through altering DNA methylation status in 
prostate cells [Ho et al., 2006].  
This dissertation covers the spectrum of the DOHaD hypothesis by linking the 
associations of developmental environmental insult (BPA exposure) and resulting adult 
phenotypes (metabolic phenotypes) to a molecular mechanistic mediator (DNA methylation). 
First, perinatal BPA exposure was associated with several metabolic phenotypes and hormone 
levels in adult age. These effects were more prominent in female, rather than male offspring. 
Second, developmental BPA exposure was linked to alterations in both global and candidate 
gene DNA methylation levels at 3 weeks of age (day 22). Third, using an epigenome-wide 
approach, perinatal BPA exposure was associated with altered DNA methylation patterns in liver 
DNA tissue at 10 months of age. Finally, meditational regression analysis suggests that DNA 
methylation is a mediator in the mechanistic pathway of BPA exposure and later in life 
phenotypes.  
 





1.3.1  Mouse Model  
This dissertation develops and utilizes a mouse model of early life (gestation and 
lactation), multiple-dose BPA exposure through the maternal diet. The dietary exposure is 
designed to alleviate maternal stress as well as mimic continual human BPA exposure, and the 
timing is designed to capture key DNA methylation reprogramming events occurring at early 
implantation [Reik et al., 2001]. Mice were generated from a colony that has been maintained 
with sibling mating and forced heterozygosity for the viable yellow agouti (A
vy
) allele for over 
220 generations, resulting in a genetically invariant background [Waterland et al., 2003]. 
Animals used in this study were maintained in accordance with the Institute of Laboratory 
Animal Resources guidelines and were treated humanely and with regard for alleviation of 
suffering. The experimental protocol was approved by the University of Michigan Committee on 
Use and Care of Animals. 
 
1.3.2  Dietary Exposure to Bisphenol A and Mating Scheme 
Virgin wild-type a/a dams, 6 weeks of age, were randomly assigned to one of four 
phytoestrogen-free AIN-93G diets (diet 95092 with 7% corn oil substituted for 7% soybean oil; 
Harlan Teklad, Madison, WI): 1) standard diet (n = 11 litters); 2) standard diet supplemented 
with 50 ng BPA/kg diet (n = 14 litters); 3) standard diet supplemented with 50 µg BPA/kg diet (n 
= 9 litters); 4) standard diet supplemented with 50 mg BPA/kg diet (n = 13 litters). All diet 
ingredients were supplied by Harlan Teklad except BPA, which was supplied by NTP (National 
Toxicology Program, Durham NC). The mg dosage is an order of magnitude lower than the 




et al., 2003], but, it is important to note, all three BPA dosages capture human environmentally 
relevant exposure [Anderson et al., 2012; Sieli et al., 2011].  
Wild-type a/a dams were provided with their respective diet two weeks prior to mating 
with 8 week old A
vy
/a males and housed in polycarbonate-free cages with ad libitum access to 
diet and BPA-free water. The dams remained on the assigned diets throughout mating, 
pregnancy and lactation, after which offspring were weaned and fed the standard phytoestrogen-
free control diet. This mating scheme produces approximately 50% a/a genotype offspring and 
50% A
vy
/a offspring. At PND 22, offspring were weighed and changed to the corn oil control 
diet. The coat color of all the A
vy
/a offspring was recorded by a single observer at this time. A 
subset of A
vy
/a and a/a wild-type mice was sacrificed at PND 22 for epigenetic analysis. A 
second subset of a/a wild-type animals was followed until 10 months of age. At 10 months of 
age the second subset was sacrificed for hormone and epigenetic analyses (Figure 1.1).  
 
1.3.2   Life-course and Epigenetic Analysis 
In the following chapters, the murine model, described in the previous section, is utilized 
to test the effects of developmental BPA exposure on metabolic and hormonal phenotypes 
throughout the life-course when the offspring are 3, 6, and 9 months of age. They undergo 
extensive phenotyping at the Animal Phenotyping Core at the Michigan Nutrition Obesity 
Research Center (MNORC) the University of Michigan. DNA methylation is explored using 
global methylation assay measuring CCGG sites and a candidate gene approach measuring 
methylation levels at seven candidate genes at PND 22, and in an epigenome-wide approach 
used to discovery novel regions of altered methylation at 10 months in BPA exposed offspring. 
Furthermore, DNA methylation is assessed as the biological target (mediator) in the development 
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CHAPTER 2  
Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and 
hormonal responses across the murine life-course 
 
2.1 Abstract  
The development of adult-onset diseases is influenced by perinatal exposure to altered 
environmental conditions. One such exposure, bisphenol A (BPA), has been associated with 
obesity and diabetes, and consequently labeled an obesogen. Using an isogenic murine model, 
we examined the effects of perinatal exposure through maternal diet to 50 ng (n=20), 50 µg 
(n=21), or 50 mg (n=18) BPA/kg diet, as well as controls (n=20) on offspring energy 
expenditure, spontaneous activity, and body composition at 3, 6, and 9 months of age, and 
hormone levels at 9 and 10 months of age. Overall, exposed females and males exhibited 
increased energy expenditure (P<0.001 and 0.001, respectively) throughout the life-course. In 
females, horizontal and vertical activity increased (P=0.07 and 0.06, respectively) throughout the 
life-course. Generally, body composition measures were not different throughout the life-course 
in exposed females or males (all P>0.44), although body fat and weight decreased in exposed 
females at particular ages (all P<0.08). Mg exposed females had improved glucose, insulin, 
adiponectin, and leptin profiles (all P<0.10). Thus, life-course analysis illustrates BPA is 
associated with hyperactive and lean phenotypes. Variability across studies may be attributable 
to differential exposure duration/timing, dietary fat/phytoestrogen content, or lack of 





Human exposure to bisphenol A (BPA), the monomer comprising polycarbonate plastic 
and epoxy-resin, is widespread, and several studies have reported detectable levels of total 
urinary BPA in a majority of individuals in populations around the world, including the United 
States, China, and Korea [Calafat et al., 2008; Zhang et al., 2011]. BPA is produced in high 
volumes and found in consumer products, such as food and water containers, baby bottles, 
receipt paper, dental composites, and metal can linings. BPA can leach from consumer products, 
which presents many opportunities for human exposure, most commonly via ingestion, and to a 
lesser extent via inhalation and dermal routes [Vandenberg et al., 2010].  
BPA can mimic or antagonize endogenous hormones, and subsequently perturb 
endocrine function [Gould et al., 1998; Kuiper et al., 1998]. For example, BPA has a strong 
binding affinity for the trans-membrane estrogen receptor (ER), G protein-coupled receptor 30 
(GPR30), and estrogen related receptor gamma (ERR γ) [Takayanagi et al., 2006; Thomas et al., 
2006]. BPA can activate transcription factors, such as peroxisome proliferator-activated 
receptors (PPARs) and the aryl hydrocarbon receptor (AhR) [Kruger et al., 2008; Sui et al., 
2012]. BPA has been labeled an environmental obesogen [Decherf et al., 2011; Heindel et al., 
2009], a xenobiotic chemical contributing to obesity and related phenotypes, due to its ability to 
interfere with the ERs α and β in adipose and pancreatic tissues and to exert antagonistic effects 
on the thyroid hormone receptor [Gould et al., 1998; Kuiper et al., 1998; Moriyama et al., 2002].  
As these receptor pathways play an important role in gene regulation, BPA may influence 
normal differentiation and maturation processes during embryonic and fetal development, 
predisposing individuals to chronic disease such as obesity throughout the life span [Bateson et 




Animal models of perinatal BPA exposure provide insight into potential alterations this 
chemical elicits on metabolic homeostasis [Heindel et al., 2009; Rubin et al., 2009]. Male 
offspring developed insulin resistance and glucose intolerance as adults when exposed to 10 µg 
BPA/kg body weight from gestational day (GD) 9-16 [Alonso-Magdalena et al., 2010]. In utero 
BPA exposure was associated with over-expression of lipogenic genes in rats, resulting in 
enhanced adipogenesis of white adipose tissue measured at post-natal day (PND) 21 [Somm et 
al., 2009]. In human adipose tissue explants, BPA inhibited the release of adiponectin and 
stimulated production of cytokines interleukin-6 and tumor necrosis factor α, common pro-
inflammatory markers found in overweight/obese individuals [Hugo et al., 2008]. In human 
epidemiological studies, Lang et al. found a positive association between adult BPA urinary 
levels and type 2 diabetes and cardiovascular disease [Lang et al., 2008], and recent data 
correlated BPA levels and obesity in children [Trasande et al., 2012]. Collectively, this work 
suggests that BPA may be a contributing factor to the obesity epidemic [Newbold, 2010]. 
Despite the increasing evidence describing BPA as an obesogen, another proposed target 
of BPA involves impairment of central nervous system (CNS) development [Masuo et al., 2011]. 
Animal studies revealed that perinatal BPA exposure was positively associated with spontaneous 
activity, aggression, and altered cognitive function [Braun et al., 2011; Kundakovic et al., 2011]. 
Zhou et al. reported that perinatal BPA exposure was associated with hyperactivity and 
decreased attention mediated by dopaminergic enhancement [Zhou et al., 2011]. Further animal 
models demonstrated that BPA targets the CNS in early development [Matsuda et al., 2010] and 
resulting behavioral outcomes correlated to human clinical disorders such as attention-deficit and 




found to be associated with maternal BPA exposure in human epidemiological studies [Braun et 
al., 2009; Zhou et al., 2011]. 
Considering the evidence from animal and human models of altered health outcomes 
resulting from early life BPA exposure, the aim of the present study was to assess the effects of 
in utero and early post-natal exposure to multiple physiologically relevant BPA levels on 
spontaneous activity, energy expenditure, body composition, and hormones/adipokines by 
incorporating sophisticated animal phenotyping at three time-points throughout the murine life-
course. Herein we report increased energy expenditure and spontaneous activity, decreased body 
weight and fat, and altered hormonal parameters across BPA exposed offspring. Effects were 
most prevalent and observed across all doses in female offspring. Males also exhibited effects, 
although they were not consistently observed across all outcomes and exposure groups.  
 
2.3 Materials and Methods 
 
2.3.1 Animals and Diets 
 Mice were obtained from a colony that has been maintained with sibling mating and 
forced heterozygosity for the viable yellow agouti (A
vy
) allele for over 220 generations, resulting 
in a genetically invariant background [Waterland et al., 2003]. Virgin wild-type a/a dams, 6 
weeks of age, were randomly assigned to one of four phytoestrogen-free AIN-93G diets (diet 
95092 with 7% corn oil substituted for 7% soybean oil; Harlan Teklad, Madison, WI): 1) 
standard diet (n=11 litters); 2) standard diet supplemented with 50 ng BPA/kg diet (n=14 litters); 
3) standard diet supplemented with 50 µg BPA/kg diet (n=9 litters); 4) standard diet 
supplemented with 50 mg BPA/kg diet (n=13 litters). All diet ingredients were supplied by 




NC). The mg dosage is an order of magnitude lower than the dietary administered maximum 
non-toxic threshold in rodents (200 mg/kg body weight/day) [Takahashi et al., 2003], but, it is 
important to note, as previously reported all three BPA dosages capture human physiologically 
relevant exposure [Anderson et al., 2012].  
Wild-type a/a dams were provided with their respective diet two weeks prior to mating 
with 8 week old A
vy
/a males and housed in polycarbonate-free cages with ad libitum access to 
diet and BPA-free water. The dams remained on the assigned diets throughout pregnancy and 
lactation, after which offspring were weaned and fed the standard phytoestrogen-free control 
diet. This mating scheme produces approximately 50% a/a genotype offspring and 50% A
vy
/a 
offspring. At PND 22, offspring were weighed and changed to the corn oil control diet. For this 
study, a subset of a/a wild-type animals, representing approximately 1 male and 1 female per 
litter were followed until 10 months of age: 1) standard diet (n=20 offspring); 2) 50 ng BPA/kg 
diet (n=20 offspring); 3) 50 µg BPA/kg diet (n=21 offspring); 4) 50 mg BPA/kg diet (n=18 
offspring). 
Animals used in this study were maintained in accordance with the Guidelines for the 
Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) and were 
treated humanely and with regard for alleviation of suffering. The study protocol was approved 
by the University of Michigan Committee on Use and Care of Animals. 
 
2.3.2 Life-course Evaluation 
Only wild-type a/a offspring were followed for life-course animal phenotyping to 
exclude bias from metabolic disturbance induced by the epigenetically-regulated A
vy
 allele in 
A
vy






/a siblings to avoid physiologic disturbances induced by singly housed 
animals. At 3, 6, and 9 months of age, energy expenditure, spontaneous activity, food intake, and 
body composition measurements were completed on a/a offspring at the Animal Phenotyping 
Core at the Michigan Nutrition and Obesity Research Center (MNORC, Ann Arbor, MI). At the 
Animal Phenotyping Core, offspring were singly housed and acclimated for a 7-day period in a 
12-hour dark/light cycle. Proceeding the 7-day acclimation period, offspring were measured for 
energy expenditure (oxygen consumption, oxygen consumption for lean body mass, and carbon 
dioxide production) sequentially every 5-seconds in 20-minute intervals throughout a 72-hour 
period using an open-circuit indirect calorimeter (Columbus Instruments Comprehensive Lab 
Animal Monitoring System , Columbus Instruments, Columbus, OH). The respiratory exchange 
ratio was measured by taking the ratio of carbon dioxide production and oxygen consumption. 
Also during the 72-hour period of testing, spontaneous activity was measured in three axes, 
including ambulatory (walking), total horizontal (ambulatory plus additional horizontal 
movement), and vertical dimensions. Motion was detected every second in 20-minute intervals 
using IR photobeam technology where the interruption of a single IR beam tallied as a “count.” 
Additionally, ad libitum food intake was measured using powdered food and a precision scale in 
20-minute increments. After completion of the 72-hour indirect calorimetry testing, body 
composition was evaluated on conscious mice through NMR (Minispec LF90II, Bruker Optics, 
Billerica, MA) imaging, distinguishing fat tissue mass, lean tissue mass, and body fluids. Body 
weight was measured before initiation of the experiments at each life-course time-point.  
 




Following the 72-hour period of CLAMS at the 9 month visit to the MNORC, animals 
were fasted for a 5-hour period and subsequently subjected to an oral glucose tolerance test 
(OGTT). Each animal received a glucose dose of 2 g/kg body weight via oral gavage. Glucose 
and insulin levels were measured at baseline, 15, 30, 60, and 120 minutes via glucometer 
(Acucheck, Roche) and ELISA (Millipore, St. Charles, MO), respectively (MNORC, Ann Arbor, 
MI).  At 10 months of age, the animals were sacrificed. Females were sacrificed on the first day 
of estrus according to vaginal cytology [Becker et al., 2005]. Serum was collected by a hepatic 
vein snip. Adiponectin and leptin serum levels were measured via ELISA according to the 
manufacturer’s instructions (Millipore, St. Charles, MO).  
 
2.3.4 Data Analysis 
Life-course energy expenditure, spontaneous activity, and food intake were evaluated at 
3, 6, and 9 months of age over a 72-hour (3-day) period in 20-minute intervals. Data were 
collapsed (averaged) to light and dark cycles, and mixed linear regression models for repeated 
measures, adjusted for sex and light cycles, were estimated. Body composition was evaluated at 
the end of the 72-hour assessment period at 3, 6, and 9 months of age; a mixed linear regression 
model was estimated, adjusting for sex. The mixed linear regression models incorporated the 
correlation within litters with a random intercept, and correlation among repeated measures 
within individual mice using an autoregressive correlation structure chosen using the maximum 
likelihood ratio test. Models were evaluated with sex-exposure, time-exposure, and sex-time-
exposure interaction terms. As a sensitivity analyses, separate models were run for each day of 
the 3-day assessment period for energy expenditure, spontaneous activity, and food intake at all 




day 3 of assessment. Hormone analyses were completed by using a repeated measures model 
accounting for within litter correlation. The homeostatic model assessment of insulin resistance 
(HOMA-IR) was performed on fasting glucose and insulin levels. Results were considered 
significant at P0.05 and marginally significant when P>0.05 and 0.10. All statistical analyses 
were completed using SAS software version 9.2 (Cary, NC).  
 
2.4 Results 
As previously reported, dietary physiologically relevant perinatal BPA exposure at 50 ng 
(n=14 litters, 107 total offspring), 50 µg (n=9 litters, 67 total offspring), or 50 mg (n=13 litters, 
91 total offspring) BPA/kg diet did not significantly influence litter size (P=0.44), survival 
(P=0.82), genotypic ratio (P=0.46), or sex ratio (P=0.16) compared to control offspring (n=11 
litters, 86 total offspring) (Table 2.1) [Anderson et al., 2012]. BPA exposure was significantly 
associated with lower wean weight of ng exposed offspring (P=0.03) but not µg or mg exposed 
offspring (Table 2.1) [Anderson et al., 2012].  
For the analysis of physiological effects across the life-course at 3, 6, and 9 months, we 
analyzed offspring exposed to 50 ng (n=20), 50 µg (n=21), or 50 mg (n=18) BPA/kg diet, as well 
as controls (n=20). Due to non-monotonic and/or non-linear trends across the life span within 
BPA dose groups, we report values for each exposure group (ng, µg, and mg) individually in 
comparison to the control group at three time-points across the life span. In addition, we report 
the general (overall) significance of each outcome across exposure groups over time.  
 




Overall, oxygen consumption differs following perinatal dietary exposure to all levels of 
BPA across the life-course for females and males (P<0.001 and 0.001, respectively). Female 
offspring exposed to 50 ng BPA/kg developed increased oxygen consumption at 6 and 9 months 
of age with an average of 5156 and 4526 ml/kg/hr compared to an average of 3814 and 3749 
ml/kg/hr in controls, respectively (P=0.09 and p<0.001, respectively) (Figure 2.1A). Females 
exposed to 50 µg BPA/kg had an average oxygen consumption of 4556 and 4301 ml/kg/hr versus 
4152 and 3814 ml/kg/hr in the controls at 3 and 6 months of age, respectively (P=0.06 and 0.02, 
respectively) (Figure 2.1A). Females exposed to 50 mg BPA/kg had an average oxygen 
consumption of 4783 and 4584 ml/kg/hr versus 4152 and 3814 ml/kg/hr in the controls at 3 and 6 
months of age, respectively (P=0.004 and P<0.001, respectively) (Figure 2.1A). At 9 months of 
age, males had oxygen consumption levels of 3713 and 3574 ml/kg/hr when exposed to 50 µg or 
mg BPA/kg, respectively compared to 3052 ml/kg/hr in controls (P=0.002 and 0.02, 
respectively) (Figure 2.1A). Additionally, oxygen consumption corrected for lean body mass 
was measured to avoid bias from inactive fat mass [Osman et al., 2000] (Figure 2.1B). Overall, 
oxygen consumption corrected for lean body mass was significantly different across exposure 
groups over the life span in females and males (P<0.001 and 0.001, respectively) (Figure 2.1B). 
Carbon dioxide production was different across exposure groups over the life-course in 
females and males (P<0.001 and 0.001, respectively).  Females exposed to 50 ng BPA/kg had 
average carbon dioxide production levels of 3897 and 3736 ml/kg/hr at 6 and 9 months of age 
versus 3487 and 3264 ml/kg/hr in the controls, respectively (P=0.07 and 0.05, respectively) 
(Figure 2.1C). Females exposed to 50 µg BPA/kg had average carbon dioxide production of 
3692 ml/kg/hr versus 3264 ml/kg/hr in controls at 9 months of age (P=0.07) (Figure 2.1C). At 3 




production levels of 3652 and 4113 ml/kg/hr versus 4057 and 3486 ml/kg/hr in controls, 
respectively (P=0.10 and 0.009, respectively) (Figure 2.1C). Males exposed to 50 µg and mg 
BPA/kg developed an average carbon dioxide production of 5858 and 4021 ml/kg/hr at 3 months 
of age, respectively, compared to 3391 ml/kg/hr in controls (P=0.04 and 0.008, respectively) 
(Figure 2.1C). Respiratory exchange ratio was calculated to determine the source of energy 
metabolism used by the exposed offspring in comparison to the controls across different time-
points over the life-course. No significant differences were observed. Additionally, the control 
group displays a natural decline in energy expenditure throughout the life-course (Figure 2.1A, 
B, and C), as noted in previous work [Goodell et al., 1998]. 
 
2.4.2 Spontaneous Activity  
Horizontal activity was different across the BPA dosages over the life-course in females, 
but not in males (P=0.07 and 0.58, respectively). Female offspring exposed to 50 ng BPA/kg had 
an average horizontal activity of 2976 and 3067 counts/hr at 3 and 9 months of age compared to 
2483 and 2591counts/hr in controls, respectively (P=0.04 and 0.05, respectively) (Figure 2.2A). 
At 9 months of age females exposed to 50 µg or mg BPA/kg displayed an average horizontal 
activity of 3241 and 3447 counts/hr, respectively, compared to 2591 counts/hr in control 
offspring (P=0.007 and P<0.001, respectively) (Figure 2.2A). Males exposed to 50 µg or mg 
BPA/kg had an average of 2740 and 2906 counts/hr in horizontal activity, respectively, 
compared to 2196 counts/hr in controls at 3 months of age (P=0.02 and 0.003) (Figure 2.2A).  
The trend in ambulatory activity was not different over the life span across the exposure 
groups in females, but the trend was different males (p = 0.36 and 0.001, respectively). However, 




ambulatory movement of 1740 and 1739 counts/hr compared to 1281 and 1372 counts/hr in 
controls, respectively, (p = 0.01 and 0.05, respectively) (Figure 2.2B). Also at 3 and 9 months of 
age, 50 µg BPA/kg exposed female offspring showed an average of 2180 and 1869 counts/hr in 
ambulatory activity compared to 1281 and 1372 counts/hr in controls (p < 0.001 and p = 0.009, 
respectively) (Figure 2.2B). Finally, at 9 months of age 50 mg exposed female offspring 
displayed average ambulatory activity of 1981 counts/hr versus 1372 counts/hr in controls (p = 
0.002) (Figure 2.2B). 
 Vertical activity was different across the exposure groups throughout the life-course in 
females, but the trend was not different in males over time (P=0.06 and 0.87, respectively). 
Females exposed to 50 ng BPA/kg dietary exposure had average vertical activity of 1202 
counts/hr at 9 months versus 874 counts/hr in controls (P=0.07) (Figure 2.2C). At 3, 6, and 9 
months of age females in the µg exposed group displayed average increase vertical activity of 
1086, 1312, and 1501 counts/hr versus 749, 987, and 874 counts/hr displayed by controls, 
respectively (P=0.06, 0.06, and P<0.001, respectively) (Figure 2.2C). At 3, 6, and 9 months of 
age, females exposed to 50 mg BPA/kg displayed average vertical activity of 1210, 1453, and 
1379 counts/hr versus 749, 987, and 874 counts/hr displayed by controls, respectively (P=0.01, 
0.01, and 0.007, respectively) (Figure 2.2C).  Vertical activity in mg exposed males at 3 months 
of age was 1267 counts/hr compared to 750 counts/hr in controls (P=0.004) (Figure 2.2C). 
Additionally, the control group displays a natural decline in spontaneous activity levels 
throughout the life-course (Figure 2.2A, B, and C), as previously observed [Stern et al., 2012]. 
 
2.4.3 Food Intake 
Food intake was different over time across the exposure groups in females and males 




of 2.12 g versus 2.40 g in controls at 6 months of age (P=0.05) (Figure 2.3). Females exposed to 
50 µg BPA/kg had average intake of 2.04 and 2.08 g at 6 and 9 months of age versus 2.44 and 
2.36 g in controls, respectively (P=0.02 and 0.10, respectively) (Figure 2.3). At 3 months of age 
the mg exposed females had average intake of 2.15 g versus 2.56 g in the controls (P=0.06) 
(Figure 2.3). At 9 months of age, ng and µg exposed males exhibited average food intake of 2.90 
and 2.34 g, respectively, versus 2.63 g in controls (P=0.10 and 0.08, respectively) (Figure 2.3).  
 
2.4.4 Day to Day Variability Assessment 
Energy expenditure, spontaneous activity, and food intake were measured over a 72-hour 
period (3-days) at each age of assessment (3, 6, and 9 months). The mice underwent a 7-day 
acclimation period prior to the onset of the 3-day phenotypic assessment, but there remained a 
possibility of variability among results from day 1 through 3 of testing. Thus, each day was 
measured separately to determine whether a particular day primarily contributed to differences 
between exposure and control groups. We found that differences among exposure groups versus 
the control group remain statistically significant from day 1 through 3 of testing. For example, 
mg exposed females had significantly higher oxygen consumption at 6 months of age on days 1, 
2, and 3 of phenotypic assessment (P=0.02, 0.03, and 0.005, respectively) (Figure 2.4), and µg 
exposed females had significantly higher ambulatory activity at 3 months of age on days 1, 2, 
and 3 of phenotypic assessment (P=0.02, P<0.001, and 0.001, respectively) compared to 
controls.  Due to homogeneous differences across the 3 days of assessment, we choose to focus 
on the average measurements across the total 3-day (72-hour) period of testing at each age of 





2.4.5 Body Composition 
Overall, body composition measures were not significantly different over the life-course 
across multiple BPA doses in females and males (all P>0.10), but significant differences 
occurred in particular exposure groups and time-points when compared to controls, especially in 
females. At 6 and 9 months of age, ng exposed females displayed an average body weight of 
27.2 and 28.4 g versus 30.9 and 32.1 g in controls, respectively (P=0.05 and 0.06, respectively) 
(Figure 2.5A). At 6 and 9 months of age, ng exposed females had an average fat mass of 4.00 
and 4.45 g versus 6.05 and 6.15 g in controls, respectively (P=0.03 and 0.08, respectively) 
(Figure 2.5B). At 3 months, of age µg exposed females had average body fat of 2.33 g versus 
4.07 g in control offspring (P=0.06) (Figure 2.5B). At 6 months of age, mg exposed females had 
average body fat of 4.50 g versus 6.05 g in controls (P=0.08) (Figure 2.5B).  There were no 
significant changes in fat mass in males (Figure 2.5B) or in lean body mass in all offspring 
across the life span (Figure 2.5C). 
 
2.4.6 Hormone Panel 
The mean baseline glucose and insulin levels in mg exposed females were lower 
compared to controls (P=0.05 and 0.10, respectively) (Figure 2.6A). The homeostatic model 
assessment of insulin resistance (HOMA-IR) was conducted to capture insulin sensitivity among 
the exposure groups. The mg exposed females displayed a HOMA index of 3.02 versus the 
control females of 8.12 (P=0.10) (Fig. 2.6C).  The mean adiponectin levels in ng and mg 
exposed females were 57.3 and 47 µg/ml, respectively, compared to 31.1 µg/ml in controls 
(P=0.02 and 0.10, respectively) (Fig. 2.6D). Alternatively, males exposed to 50 µg BPA/kg had 




mg exposed females were 11.1 ng/ml compared to female control serum levels of 18 ng/ml 
(P=0.10) (Figure 2.6E).   
 
2.5 Discussion 
Offspring exposed to 50 ng, µg, and mg of BPA/kg of diet during gestation and lactation 
developed an overall increase in energy expenditure throughout their life-course, measured via 
indirect calorimetry in comparison to unexposed control offspring across a 72-hour period. There 
are limited studies exploring in utero environmental exposures, especially BPA, and their impact 
on oxygen consumption and carbon dioxide production. McKenzie et al. [McKenzie et al., 2007] 
explored heavy metal and organic compound (PAHs, PCBs, and OCPs) exposure on the 
metabolic rate of adult fish in different geographical species and reported that exposed cyprinid 
fish in the Netherlands developed an increased resting metabolic rate. In contrast to the increased 
energy expenditure observed in our perinatal BPA exposure offspring cohort, adult short-term 
BPA exposure to 100 µg/kg body weight via injection in mice resulted in decreased energy 
expenditure indicating that timing, duration, and route of BPA exposure may have differing 
effects on metabolic endpoints [Batista et al., 2012].  
 Corresponding to the observed increase in energy expenditure in the current study, 
spontaneous activity levels were increased in offspring following perinatal BPA exposure with 
outcomes more prominent among females. The hyperactive phenotype found in animal models is 
analogous to human clinical disorders like ADHD and aggression [Wolstenholme et al., 2011]. 
Multiple animal models have been used to assess early life exposure to BPA and its effect on 
activity and behavioral-related outcomes. In mice, a single oral dose of 0.32, 3.2, or 4.8 mg 
BPA/kg body weight at PND 10 initiated hyperactivity in males as adults [Viberg et al., 2011]. In 




10, Zhou et al. [Zhou et al., 2011] reported increased activity and discovered corresponding 
alterations to the dopaminergic system, which is a known target in disorders like ADHD [Ishido 
et al., 2005]. Zebrafish larvae exposed to 0.01 and 0.1, µM of BPA for 48 hours during post-
fertilization revealed hyperactivity as adults compared to unexposed controls [Saili et al.]. 
Furthermore, human epidemiological evidence noted positive relationships among maternal 
gestational urinary BPA levels and hyperactivity and aggression in children, especially in 
females [Braun et al., 2011; Braun et al., 2009]. 
 In this present study, sophisticated NMR body composition analysis revealed marginally 
significant changes in body weight and fat mass. In a previous report, female and male rats 
exposed to 2.5 or 5 µg BPA/kg body weight per day from GD 6 through PND 21 had 
significantly lower body weights compared to controls from PNDs 0 to 21 [Ferguson et al., 
2011]. Using repeated body weight measurements, CD-1 mice exposed to dietary BPA during 
gestation and lactation were heavier than controls at 4 weeks of age, but this association was 
diminished in adulthood, and the effect did not persist in offspring fed a high fat diet [Ryan et al., 
2010]. Alternatively, Wei et al. [Wei et al., 2011] looked at perinatal exposure to several doses 
of BPA by oral gavage in rats. As adults, offspring developed increased body weight when 
exposed to 50 µg/kg perinatally, which was exacerbated when offspring were fed a high fat diet. 
Female offspring exposed to 70 µg BPA/kg body weight per day via maternal drinking water 
from GD 6 through lactation displayed increased body weight upon weaning, with a 
corresponding increase in white adipose tissue and expression of lipogenic genes [Somm et al., 
2009].  
With much attention focused on body weight and composition after early life BPA 




and glucose tolerance as metabolic endpoints. Within this study, our fasting glucose and insulin 
tolerance test revealed an increase in insulin sensitivity with further validation using the HOMA-
IR index in females treated with 50 mg BPA/kg diet in utero and through lactation. Conflicting 
evidence has emerged in the literature indicating BPA exposure in early development induces 
early signs of type 2 diabetes and metabolic syndrome such as glucose intolerance and insulin 
resistance [vom Saal et al., 2012].  For instance, male rat offspring from dams fed a BPA 
supplemented diet during gestation exhibited glucose intolerance and insulin insensitivity at 6 
months of age [Alonso-Magdalena et al., 2010]. Adult female and male rats exposed to BPA in 
utero, displayed altered glucose and insulin homeostasis which exacerbated in males on a high 
fat diet [Wei et al., 2011].  
We found that exposure to 50 ng and mg of BPA/kg diet increased serum adiponectin 
levels in female adult offspring. Adiponectin enhances insulin responsiveness and glucose 
uptake, is mainly produced by adipose tissue, and is negatively correlated with fat mass in 
humans [Ahima, 2006]. Previous reports have shown that BPA inhibits the release of adiponectin 
from human adipose tissue suggesting that BPA may promote the development of insulin 
resistance [Ben-Jonathan et al., 2009]. Interestingly, the elevated levels of adiponectin in our 
study were seen concurrently with increased spontaneous activity and reduced fat mass in ng and 
mg exposed female offspring, and reduced insulin and HOMA-IR in mg exposed female 
offspring with modestly lower levels of glucose during an OGTT.  Thus, our data suggest that 
perinatal exposure to BPA elevates adiponectin and this may have occurred as a consequence to 
hyperactivity and reduced body fat. Of note, significant effects on these endpoints were not 




exposure, an area of active interest and investigation [Anderson et al., 2012; Jones et al., 2012; 
Vandenberg et al., 2012]. 
We report significantly decreased serum leptin following exposure to 50 mg BPA among 
females and modestly lower (non-significant) leptin levels among µg and ng, and µg and mg 
exposed females and males, respectively. Leptin is a hormone produced by adipose tissue that is 
positively correlated with body fat mass and plays a key role in energy homeostasis [Ahima, 
2006]. There are limited in vivo studies on leptin following BPA exposure. Briefly, one study has 
shown that perinatal BPA exposure resulted in increased serum leptin levels in both females and 
males on both a high fat and normal fat diet which was positively associated with body fat [Wei 
et al., 2011]. In another report, serum leptin levels at PND 21 were unchanged versus controls in 
rats exposed to 2.5 or 5 µg BPA/kg body weight per day perinatally [Ferguson et al., 2011]. In 
contrast to previous reports, our data proposes that decreased leptin levels are correlated with 
reduced body fat following perinatal BPA exposure. 
Alterations in metabolic phenotypes in BPA exposed offspring were more prominent in 
females than males, within the current study. Other literature describes early life BPA exposure 
resulting in gender specific outcomes as well [Braun et al., 2011]. Early life BPA exposure can 
affect sexually dimorphic traits in vivo when normal circulating levels of androgens are needed 
during brain development to shape sexually distinct behaviors [Jašarević et al., 2011; Patisaul et 
al., 2008; Wolstenholme et al., 2011]. 
 
2.6 Conclusion 
Variable outcomes across studies highlighted throughout this discussion may be 




of sophisticated measurements of body composition and energy expenditure conducted at 
multiple time-points across the life-course. Of note, our exposure paradigm included a 
phytoestrogen-free and non-high fat background diet. Future studies are needed to evaluate 
whether diet modifies the effects of perinatal BPA exposure on metabolic and hormonal 
parameters throughout the life-course. Studies will need to continue to focus on timing of 
exposure, dose levels (particularly doses relevant to human exposure), and differences among 
strains and species in order to elucidate the complete phenotypic depiction of early life BPA 
exposure on the development of adult disease. Additionally, the effected biological pathways 
will need to be determined, for example, by evaluating epigenome-wide methylation and 
chromatin profiles, in order to understand the mechanism linking early BPA exposure to later-in-

















Table 2.1 Litter parameters. Offspring litter size, survival rate, wean weight, genotypic ratio, 















control 11 7.82 0.95 9.28 55 45 
mg 13 7.00 0.95 9.27 51 51 
µg 9 7.44 0.91 9.33 52 54 
ng 14 7.64 0.93    8.65** 55 57 























Figure 2.1 Energy expenditure (ml/kg/hr) measured by indirect calorimetry over a 72-hour period 
 
 
A) Oxygen consumption, B) carbon dioxide consumption, and C) carbon dioxide production across the 
life-course stratified by offspring sex. P-values represent ng (n=10 female and 10 male), µg (n=10 female 
and 11 male), or mg (n=9 female and 9 male) BPA exposed offspring compared to control offspring 




Figure 2.2 Spontaneous activity (counts/hr) measured via IR photo-beam detection average over a 72-
hour period 
 
A) Horizontal, B) ambulatory, and C) vertical activity across the life-course stratified by offspring sex. P-
values represent ng (n=10 female and 10 male), µg (n=10 female and 11 male), or mg (n=9 female and 9 





Figure 2.3 Food intake 
 
Food intake (g) across the life-course measured by powdered food on a precision scale over a 72-hour 
period stratified by offspring sex. P-values represent ng (n=10 female and 10 male), µg (n=10 female and 
11 male), or mg (n=9 female and 9 male) BPA exposed offspring compared to control offspring (n=10 
















Figure 2.4 Oxygen consumption (ml/kg/hr) as a representative example of day by day variability analysis 
 
Oxygen consumption A) collapsed over the 72-hr period of testing across the life-course, B) day 1 across the life-course C) day 2 across the life-
course, and D) day 3 across the life-course stratified by offspring sex. P-values represent ng (n=10 female and 10 male), µg (n=10 female and 11 




Figure 2.5 Body composition 
 
Body composition (g) measured via nuclear magnetic resonance. A) Body weight, B) body fat, and C) 
lean body mass across the life-course stratified by offspring sex. P-values represent ng (n=10 female and 
10 male), µg (n=10 female and 11 male), or mg (n=9 female and 9 male) BPA exposed offspring 





Figure 2.6 Hormone Panel 
 
Hormones measured at 9 or 10 months of age. A) Glucose (mg/dl) and insulin (ng/ml), measured via a 
fasting oral glucose tolerance test (OGTT) at baseline, 15, 30, 60, and 120 minutes at 9 months of age. P-
values represent ng (n=9 female)###, µg (n=10 female) or mg (n=9 female) BPA exposed offspring 
compared to control offspring (n=9 female)###. B) Glucose (mg/dl) and insulin (ng/ml), measured via a 
fasting oral glucose tolerance test (OGTT) at baseline, 15, 30, 60, and 120 minutes at 9 months of age. P-
values represent ng (n=10 male), µg (n=11 male), or mg (n=9 male) BPA exposed offspring compared to 
control offspring (n=10 male). C) Homeostatic model assessment of insulin resistance calculated from 
fasting OGTT scores. D) Adiponectin (µg /ml) and E) leptin (ng/ml) measured via ELISA at 10 months 
of age. P-values represent ng (n=9 female and 10 male)###, µg (n=10 female and 11 male), or mg (n=9 
female and 9 male) BPA exposed offspring compared to control offspring (n=9 female and 10 male)###. 
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Epigenetic responses following maternal dietary exposure to physiologically relevant levels 
of bisphenol A 
 
 
3.1  Abstract 
Animal studies have linked perinatal bisphenol A (BPA) exposure to altered DNA 
methylation, but little attention has been given to analyzing multiple human physiologically 
relevant doses. Utilizing the viable yellow agouti (A
vy
) murine mouse model, we examine the 
effects of developmental exposure through maternal diet to 50 ng BPA/kg (n=14 litters), 50 µg 
BPA/kg (n=9 litters), or 50 mg BPA/kg (n=13 litters) on global and candidate gene methylation 
in tail and liver tissue at post-natal day 22. Global methylation analysis reveals hypermethylation 
in tail tissue of a/a and A
vy
/a offspring across all dose groups compared to controls (n=11 litters; 
P<0.02).  Analysis of coat color phenotype replicates previous work showing that the 
distribution of 50 mg BPA/kg A
vy
/a offspring shifts toward yellow (P=0.006) by decreasing 
DNA methylation in tail tissue of the retrotransposon upstream of the Agouti gene (P=0.03).  
Maternal exposure to 50 µg or 50 ng BPA/kg, results in altered coat color distributions in 
comparison to control (P=0.04 and 0.02), but no DNA methylation effects at the Agouti gene are 




) metastable epiallele in 
tail tissue shows hypermethylation in the 50 µg BPA/kg offspring, compared to controls 




DNA methylation at the imprinted locus H19 shows hypomethylation (P=0.06) in the 50 µg 
BPA/kg offspring, and hypermethylation at the imprinted locus Igf2 in the 50 mg and 50 ng 
BPA/kg offspring (P=0.008 and 0.03, respectively). Comparison of exposed mouse liver BPA 
levels to human fetal liver BPA levels indicates that the three experimental exposures are 
physiologically relevant. Thus, perinatal BPA exposure affects offspring phenotype and 
epigenetic regulation across multiple doses, indicating the need to evaluate dose effects in human 
clinical and population studies.  
 
3.2  Introduction 
A growing body of work supports the developmental origins of health and disease 
(DOHaD) hypothesis, in which chemical and nutritional exposures early in development 
influence chronic disease outcomes in adulthood [Barker, 2004; Bateson et al., 2004]. Epigenetic 
modifications, such as DNA methylation and histone modifications, established early in 
development can shape susceptibility to disease, resulting in diverse phenotypes among 
genetically identical individuals [Rakyan et al., 2002]. For example, metastable epialleles are 
genes that are variably expressed due to epigenetic modifications established early in 
development, and thus increasingly susceptible to environmental disruption during gestation 







) in which the activity of a contraoriented intracisternal A 
particle (IAP) retrotransposon controls expression of an adjacent gene (Figure 3.1) [Druker et 
al., 2004; Duhl et al., 1994; Rakyan et al., 2002; Ruvinsky et al., 2001; Vasicek et al., 1997]. 
Importantly, the distribution of DNA methylation patterns at these metastable epialleles have 




bisphenol A (BPA) [Cooney et al., 2002; Dolinoy et al., 2007; Dolinoy et al., 2006; Kaminen-
Ahola et al., 2010; Waterland et al., 2003].  
Accumulating work suggests that early bisphenol A (BPA) exposure increases 
susceptibility for adverse phenotypic outcomes via epigenetic mechanisms. BPA is a chemical 
used for the industrial manufacturing of polycarbonate plastics and epoxy resins. There are 
multiple routes of BPA exposure including ingestion, dermal absorption, and inhalation due to its 
widespread use in commercial products such as food and beverage containers, baby bottles, 
dental sealants, and receipt paper [Vandenberg et al., 2007]. Recurrent exposure to BPA is 
evident from detectable levels present in greater than 92% of the United States population 
[Calafat et al., 2008]. As an endocrine active compound, BPA can exert estrogenic activity by 
interfering with estrogen receptors alpha and beta, and estrogen related receptor gamma even at 
low exposure levels [vom Saal et al., 2006].  
Early exposure to BPA may promote chronic disease development such as prostate and 
breast cancer, type 2 diabetes, and obesity as well as impaired brain development and behavior 
by altering the developing epigenome [Jirtle et al., 2007; Kundakovic et al., 2011], thus genomic 
loci other than metastable epialleles have examined for epigenetic disruption. For example, early 
developmental exposure to 10 µg BPA/kg BW/day decreased methylation of the 
phosphodiesterase type 4 variant 4 gene in prostate cancer cells in adult male rats [Ho et al., 
2006; Prins et al., 2008]. Additionally, in utero exposure to 5 mg BPA/kg BW in CD-1 mice on 
days 9-16 of pregnancy decreased methylation in the promoter region of Hoxa10, a gene 
involved in uterine organogenesis [Bromer et al., 2010]. Previously, our group reported a shift 
towards DNA hypomethylation at the viable yellow agouti (A
vy
) and CDK5 activator binding 
protein  (Cabp
IAP




high dosage of BPA (50 mg BPA/kg diet) perinatally [Dolinoy et al., 2007]. Moreover, 
restoration of normal methylation patterns occurred with maternal supplementation of genistein 
or methyl donors such as folate, choline, betaine, and vitamin B12 [Dolinoy et al., 2007; Dolinoy 
et al., 2006].  
Previous epigenetics studies involving BPA have not captured the full range of human 
physiologically relevant exposure levels, and most attempts to elucidate the effects on the 
epigenome following environmental manipulations, including perinatal exposure to BPA, have 
been restricted in dose-response assessment. Thus, utilizing the viable yellow agouti (A
vy 
) mouse 
model, we examined global and candidate gene methylation patterns following perinatal 
exposure at three dosages (50 ng, µg, and mg of BPA/kg diet). The murine A
vy
 allele resulted 
from the random insertion of a murine IAP retrotransposon into the 5’ end of the Agouti gene 
(Figure 3.1A) [Duhl et al., 1994]. Methylation of CpG sites in and near the A
vy
 IAP correlates 
inversely with ectopic Agouti expression and varies dramatically among isogenic A
vy
/a mice, 
resulting in a wide array of coat colors, ranging from yellow (unmethylated) to pseudoagouti 
(methylated), and additionally results in adult-onset obesity (~10 weeks of age) among low 
methylated mice [Miltenberger et al., 1997; Morgan et al., 1999]. To our knowledge, this is the 
first study to utilize the A
vy
 mouse model as an epigenetic biosensor to evaluate maternal 
exposure to multiple, rather than single dose levels.  
 
3.3  Materials and Methods 
 
3.3.1 Animals and Diets 
A
vy
 mice were obtained from a colony that has been maintained with sibling mating and 
forced heterozygosity for the A
vy




invariant background [Waterland et al., 2003]. Virgin a/a dams, 6 weeks of age, were randomly 
assigned to one of four phytoestrogen-free AIN-93G diets (diet 95092 with 7% corn oil 
substituted for 7% soybean oil; Harlan Teklad, Madison, WI): 1) standard diet (n=11 litters, 86 
total offspring, 39 A
vy
/a offspring); 2) standard diet supplemented with 50 ng BPA/kg diet (n=14 
litters, 107 total offspring, 48 A
vy
/a offspring); 3) standard diet supplemented with 50 µg BPA/kg 
diet (n=9 litters, 67 total offspring, 32 A
vy
/a offspring); 4) standard diet supplemented with 50 mg 
BPA/kg diet (n=13 litters, 91 total offspring, 45 A
vy
/a offspring). All diet ingredients were 
supplied by Harlan Teklad except BPA, which was supplied by NTP (National Toxicology 
Program, Durham NC). The mg dosage was formulated to be an order of magnitude lower than 
the dietary administered maximum non-toxic threshold in rodents (200 mg/kg BW/day) 
[Takahashi et al., 2003], while the ng and µg BPA dosages were used to potentially capture the 
physiologically relevant range of human exposure.  
Following 2 weeks on their respective diets, at 8 weeks of age a/a virgin dams were 
mated with A
vy
/a males, 8 weeks of age. All animals were housed in polycarbonate-free cages 
and provided ad libitum access to diet and BPA-free water. The dams remained on the assigned 
diets throughout pregnancy and lactation. At post-natal day 22 (PND 22), a/a and A
vy
/a offspring 
were weighed and a tail sample was collected. Also at PND 22, a single observer visually 
classified A
vy
/a offspring coat color phenotype into one of five categories based on proportion of 
brown fur: yellow (<5% brown), slightly mottled (between 5% and 40% brown), mottled (~50% 
brown), heavily mottled (between 60% and 95% brown), and pseudoagouti (>95% brown). Tail 
tissue was collected for analysis from all offspring.  
Animals used in this study were maintained in accordance with the Guidelines for the 




treated humanely and with regard for alleviation of suffering. The study protocol was approved 
by the University of Michigan Committee on Use and Care of Animals. 
 
3.3.2 DNA Isolation and Methylation Analysis 
Total genomic DNA was isolated from PND 22 tail tissue of all a/a and A
vy
/a offspring 
using magnetic particle-based methodology and the Maxwell 16® Instrument (Promega 
Corporation, Madison, WI). Total genomic DNA was isolated from PND 22 liver of all a/a and 
A
vy
/a offspring using a standard phenol-chloroform extraction method. Briefly, about 15 mg of 
tissue was resuspended in 540 ul buffer ATL and is homogenized for 20 seconds at 15 Hz 
(TissueLyser, Qiagen). The lysate was transferred to 60 ul of Proteinase K and incubated for 
overnight at 50C. After overnight incubation 12 ul of RNase A is added to lysate and incubated 
for 10 minutes at 37C. Samples are extracted twice with 600 ul phenol–chloroform–isoamyl 
and once with 600 ul chloroform. 50L of 3M sodium acetate is added to aqueous phase and 
precipitated with 1 mL ice-cold 100% ethanol. For additional precipitation, 1 mL of ice-cold75% 
ethanol is added to pellet twice. The pellet was air dried and resuspended with 100 ul Tris-EDTA 
buffer and incubated for 2 hours at 60C with frequent mixing.  
 The Luminometric Methylation Assay (LUMA), a methylation-sensitive restriction 
enzyme digest followed by quantitative DNA methylation analysis via pyrosequencing, was 
utilized to analyze global DNA methylation at CCGG sites throughout the mouse genome using 
genomic tail DNA [Karimi et al., 2006]. Approximately 300 ng of genomic tail DNA was 
digested with both HpaII, an endonuclease sensitive to CpG methylation, and MspI, an 
endonuclease insensitive to CpG methylation; both endonucleases cut CCGG sites between the 




normalization reference [Karimi et al., 2006]. Following DNA digestion, samples were 
pyrosequenced in duplicate to quantify CCGG DNA methylation. The pyrosequencing output 
provides the incorporation of dCTP, which is directly correlated with DNA methylation. The 
ratio of digested sites to undigested sites was calculated and represents the percentage of 
genomic DNA methylation. Duplicates with measurement differences greater than 15% were 
omitted prior to statistical analysis. 
Using the Qiagen Epitect kit automated on the Qiagen QIAcube® purification system, 
approximately 1 µg of genomic tail and liver DNA was treated with sodium bisulfite to allow 
conversion of unmethylated cytosines to uracil, read as thymine during polymerase chain 
reaction (PCR), whereas the methylated cytosines remain unconverted [Grunau et al., 2001]. 
Following bisulfite conversion, candidate gene regions of interest were amplified using 
HotStarTaq master mix (Qiagen Inc., Valencia, CA), forward primer (0.5 pmol) and reverse 
primer (0.5 pmol) in a 30 µL PCR and resolved by gel electrophoresis. PCR and sequencing 
primers for assays are listed in Table 3.1. DNA methylation of CpG sites of interest was 
quantified using PyroMark MD (Qiagen Inc., Valencia, CA) pyrosequencing technology. Percent 
methylation was computed using PyroMark software, which calculates the degree of methylation 
as percent 5-methylated cytosines (%5mC) over the sum of methylated and unmethylated 
cytosines. All samples were run in duplicate using the average CpG site methylation of the 
duplicates for statistical analysis. Sequences to analyze for pyrosequencing runs are provided in 
Table 3.1. The four CpG sites studied at the A
vy
 allele are located at nucleotide positions 306, 
319, 322, and 334 of GenBank accession number AF540972.1. The four CpG sites studied at the 
Cabp
IAP
 allele are located at nucleotide positions 44, 57, 60 and 72 of GenBank accession 




methylated region 2 (DMR2), and the four sites studied at the H19 allele are located in the 
imprinted control region. The five, three, and two CpG sites studied at HsdBeta11 Type 2, Ppar-
alpha, and Ppar-gamma, respectively are located 150 bp, 400 bp, 260 bp upstream of the TSS in 
the promoter region. 
 
3.3.3 Statistical Analysis 
 The influence of gestational BPA exposure on litter size, survival, wean weight, 
genotypic ratio, and sex ratio was evaluated using ANOVA with Bonferroni post-hoc analysis. 
The distribution of the five coat color phenotypes between each exposure group was analyzed 
using a chi-square goodness-of-fit test, with the control coat color distribution representing the 
expected distribution.  All comparisons resulted in cell counts with no more than 20% of cells 
containing fewer than 5 observations. The influence of sex, genotype and coat color on mean 
CpG methylation was measured using ANOVA with Bonferroni corrections. Average CpG 




, and global 
methylation among the three BPA exposed groups and the control group were evaluated by two-
sample hypothesis analysis of means and ANOVA with Bonferroni correction as post-hoc 
analyses. Average and site-specific CpG methylation for H19, Igf2, HsdBeta11 Type 2, Ppar-
alpha, and Ppar-gamma were evaluated using a mixed effects regression model to account for 
correlation among CpG sites within an amplicon using an unstructured covariance structure 
chosen from the maximum likelihood ratio test. Models were evaluated with a CpG site-exposure 
interaction term. Two additional mixed effects regression models were conducted to stratify by 
sex and genotype to determine their influence on methylation results. Statistical significance was 




histograms and Q-Q plots. Outliers defined as having a studentized residual greater than 2.0 were 
excluded in the final methylation analysis. The resulting exclusion of outliers consisted of two 
mg exposed subjects for A
vy
 locus methylation analysis. All statistical analyses were completed 
using SAS software version 9.2 (Cary, NC). 
 
3.3.4 BPA Analysis in Liver  
Approximately 300-500 mg of PND 22 A
vy
/a mouse liver tissue (n=8-11 per exposure 
group) was flash frozen and homogenized to fine powder over a mortar above liquid nitrogen. 
Homogenized tissue was transferred into a 2 mL polypropylene eppendorf tube and transported 
overnight on dry ice to the Wadsworth Center (New York State Department of Health, Albany, 
NY). Five mL of acetonitrile and 5 ng of 
13
C12-BPA, an internal standard, were added to 
homogenized tissue, and the mixture was shaken for 30 minutes.  Extraction with acetonitrile 
was repeated twice and the mixture was centrifuged at 4500 x g for 3 minutes. Combined 
aliquots were concentrated to near-dryness under a gentle stream of nitrogen and reconstituted 
with 1.5 mL of 10% dichloromethane in hexane. The sample extract was then loaded onto a 
Strata® NH2 cartridge (200 mg/3 mL, Phenomenex, Torrance, CA), pre-conditioned with 5 mL 
of 80% methanol in acetone and 5 mL of hexane. The cartridge was washed with 5 mL of hexane 
and eluted with 5 mL of 80% methanol in acetone. The eluate was concentrated to 0.5 mL under 
a gentle stream of nitrogen resulting in the free BPA fraction.  
To determine conjugated BPA, 1 mL of Milli-Q H2O and 1 mL of 2 µL/mL β-
glucuronidase (from Helix pomatia, 145700 units/mL, Sigma, St Louis, MO) were added to the 
residue from free-BPA aliquot. 
13
C12-BPA was added and digested at 37
o
C for 12 hours. The 




through Strata® NH2 cartridge as described above. The final eluate was concentrated to 0.5 mL. 
A high-performance liquid chromatograph (HPLC) interfaced with API 2000 electrospray triple-
quadruple mass spectrometry (ESI-MS/MS; Applied Biosystems, Foster City, CA) was used for 
the quantification of free and conjugated BPA [Padmanabhan et al., 2008]. Ten µL of the extract 
was injected onto an analytical column (Betasil® C18, 100 × 2.1 mm column; Thermo Electron 
Corporation, Waltham, MA), which was connected to a Javelin® guard column (Betasil® C18, 
20 × 2.1 mm). The mobile phase flow rate was 300 µL/min. The mobile phase consisting of 
methanol and water started at a gradient of 25% methanol to 99% methanol in 4 minutes and was 
held for 10 minutes before reverting to its initial condition. The MS/MS was operated in the 
electrospray negative ionization mode and optimized to transmit the [M-H]
-
 ion before 
fragmentation of one or more product ions. Cone voltage and collision energies were 30 V and 
25 V, respectively. The capillary voltage was 4.5 KV, and desolvation temperature was 400
o
C. 
Multiple reaction monitoring transitions monitored were 227 > 212 for BPA, and 239 > 224 for 
13
C12-BPA.  
A procedural blank was analyzed with every 10 samples to check for interferences or 
laboratory contamination. The limit of quantitation (LOQ) of BPA was 0.1 ng/g. The LOQ was 
calculated as twice the concentration of the "lowest acceptable calibration standard"; the amount 
of sample taken for analysis and final extract volume. The mean recovery of 
13
C12-BPA spiked 
into samples was 96%. Reported concentrations were corrected for the recoveries of the internal 
standard (isotope dilution method). BPA standards spiked into selected sample matrices and 
passed through the entire analytical procedure yielded a mean recovery of 101%. An external 
calibration curve was prepared by injecting 10 µL of 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 50, and 100 




 In order to compare mouse liver BPA concentrations to physiologically relevant levels in 
humans, free and conjugated BPA were measured in 51 human fetal liver samples obtained from 
the NIH-funded (R24 HD000836-47) Birth Defects Research Laboratory fetal tissue bank at the 
University of Washington, Seattle. These tissues were derived from conceptuses with gestational 
ages ranging from 74 to 120 days. Information provided with these tissues include gestational 
age and sex; occasionally race is indicated. The health status of the individuals is unknown but 
presumed to have been healthy and with no known chromosomal abnormalities. Prior to 
shipment to the University of Michigan, samples were flash frozen with liquid nitrogen and 
stored in polycarbonate-free tubing. Fetal liver tissues were processed for BPA levels as 
described above.  
To ensure no contamination was introduced into the sample preparation process, a 
negative control of BPA-free water was processed identically as the mouse and human samples 
described above and resulted in free and conjugated BPA levels below the LOQ. For calculation 
of mean and median BPA concentrations, liver BPA levels below the LOQ were assigned a value 
of 0.071, which was estimated by dividing the LOQ (0.1 ng/g) by the square root of 2. 
 
3.4  Results 
 
3.4.1 Overview 
Gestational BPA exposure at 50 ng BPA/kg (n=14 litters, 107 total offspring), 50 µg 
BPA/kg (n=9 litters, 67 total offspring), or 50 mg BPA/kg (n=13 litters, 91 total offspring) diet 
did not significantly influence litter size (P=0.84), survival (P=0.86), genotypic ratio (P=0.49), 
or sex ratio (P=0.16) in comparison to control offspring (n=11 litters, 86 total offspring) (Table 




exposed a/a and A
vy
/a offspring (mean weight 8.65 g in ng versus 9.28 g in control; P=0.03) but 
not µg or mg exposed offspring (Table 2.1). When PND 22 body weight analysis is restricted to 
a/a animals only, the decreased body weight in ng exposed offspring, and not in µg and mg 
exposed offspring, is still observed (mean weight 8.24 g in ng versus 9.15 g in control; P=0.01). 
 
3.4.2 Global DNA Methylation  
 Global CCGG DNA methylation levels throughout the mouse genome were measured in 
A
vy
/a and a/a offspring PND 22 tail DNA using the LUMA assay (Table 3.2). Mean methylation 
did not differ by sex (P=0.58), genotype (P=0.43), or coat color (P=0.93). Offspring exposed to 
the 50 mg BPA/kg diet demonstrated an average of 59.3% global DNA methylation in 
comparison to control offspring with measured percent global methylation of 51.6 (n=71 and 60, 
respectively; P=0.01).  Offspring exposed to the 50 µg BPA/kg diet also exhibited significantly 
higher average percent global DNA methylation of 60.3 compared to controls (n=52 and 60, 
respectively; P=0.008). Lastly, the offspring exposed to a 50 ng BPA/kg diet showed 
significantly higher average percent global methylation of 58.8 compared to controls (n=74 and 
60, respectively; P=0.02).  There were no statistically significant differences in global 
methylation among the three BPA exposed groups.  
 
3.4.3 Maternal Dietary BPA Exposure Coat Color Shift   
 The total number of offspring evaluated for coat color shift was among 11 litters from the 
corn oil control group (n=39 A
vy
/a offspring), 13 litters from the mg BPA/kg supplemented group 
(n=45 A
vy
/a offspring), 9 litters from the µg BPA/kg supplemented group (n=32 A
vy
/a offspring), 
and 14 litters from the ng BPA/kg supplemented group (n=48 A
vy




exposure through maternal diet shifted the coat color distribution of A
vy
/a offspring in a dose-
dependent fashion. Maternal dietary exposure to 50 mg BPA/kg shifted the coat color 
distribution of genetically identical PND 22 A
vy
/a offspring towards yellow in comparison to 
control offspring (P=0.006) (Figure 3.2A). Twenty-nine percent of the 50 mg BPA/kg exposed 
offspring were classified as yellow coat color compared to only 15% of control offspring. 
Conversely, maternal dietary exposure to 50 µg BPA/kg resulted in a statistically significant 
altered coat color distribution in comparison to controls (P=0.04) (Figure 3.2B). Twenty-five 
percent of the 50 µg BPA/kg exposed offspring were classified as pseudoagouti compared to 
only 12% of the control offspring; however the 50 µg BPA/kg exposed offspring were also more 
likely to be classified as slightly mottled (31% compared to 18%). Finally, maternal dietary 
exposure to 50 ng BPA/kg resulted in increased incidence of slightly mottled and heavily mottled 
offspring compared to controls (P=0.02) but did not shift the coat color distribution towards the 
pseudoagouti or yellow phenotype (Figure 3.2C).  
 




 metastable epialleles 
Site-specific and average CpG DNA methylation in PND 22 tail tissue at four CpG sites 
(sites 6-9) in the cryptic promoter of the A
vy
 IAP was quantified using bisulfite pyrosequencing 
on A
vy
/a offspring (Figure 3.1A).  The mg exposure group (n=43 A
vy
/a offspring) demonstrated 
an average methylation of 24.3% across the four CpG sites in comparison to 35.6% average 
methylation of the controls (Table 3.3) (n=38 A
vy
/a offspring; P=0.03). Evaluation of each 
individual CpG site indicated a significant decrease in methylation at sites 6 (P=0.03), 7 
(P=0.02) and 8 (P=0.02) in the mg exposed offspring versus control. Methylation at site 9 was 






/a offspring; P=0.97) and ng (n=48 A
vy
/a offspring; P=0.79) exposed offspring did 
not differ in comparison to the control group (Table 3.3). There were no significant differences 
in methylation at sites 6-9 of µg (P=0.96. 0.93, 0.99, and 0.80, respectively) and ng (P=0.79, 
0.60, 0.75, and 0.99, respectively) groups in comparison to the control group. 
 DNA methylation in PND 22 tail tissue at four CpG sites (sites 6-9) in the Cabp
IAP 
metastable epiallele [Druker et al., 2004] was measured in both A
vy
/a and a/a offspring (Figure 
3.1B). In comparison to the control group (n=82 A
vy
/a and a/a offspring), the mg exposed 
offspring (n=85 A
vy
/a and a/a offspring) showed no difference in average methylation across the 
four CpG sites (83.1% versus 83.6%, respectively; P=0.64) (Table 3.3). Average methylation 
across the four CpG sites in the µg exposed offspring (n=67 A
vy
/a and a/a offspring), however, 
was increased compared to controls (85.8% and 83.1%, respectively; P=0.02). Site-specific 
methylation showed increased methylation at sites 6, 8, and 9 in the µg exposed group versus the 
controls (P=0.01, 0.02, and 0.04, respectively). The ng exposure group (n=107 A
vy
/a and a/a 
offspring) displayed an average methylation across the four CpG sites of 84.3% compared to 
83.1% in the control group (P=0.25). Sites 8 and 9 exhibited statistically significant increased 
methylation in ng exposed offspring when compared to controls (P=0.02 and 0.04, respectively). 
 
3.4.5 Candidate Gene DNA Methylation at Ppar-alpha, Ppar-gamma, HsdBeta11 Type 2, 
Igf2, and H19  
DNA methylation in PND 22 liver tissue at four CpG sites in the imprinted gene H19 was 
measured in both A
vy
/a and a/a offspring. In comparison to the control group (n=37 A
vy
/a and a/a 
offspring), the mg and ng exposed offspring (n=40 and 46 A
vy
/a and a/a offspring, respectively) 




54.0%, respectively; P=0.47 and 0.72, respectively) (Figure 3.3A). Alternatively, the µg 
exposed group (n=24 A
vy
/a and a/a offspring) displayed a marginally significant decrease in 
average methylation compared to the control group (52.2% versus 54.4%, respectively; P=0.06) 
(Figure 3.3A).  
Also in PND 22 liver tissue, DNA methylation at eight CpG sites was measured in the 
imprinted gene Igf2. The µg exposed group (n=22 A
vy
/a and a/a offspring) showed no significant 
changes in average methylation compared to the control group (n=36 A
vy
/a and a/a offspring; 
39.3% versus 40.6%, respectively; P=0.31) (Figure 3.3B). In comparison to the control group, 
the mg and ng exposed offspring (n=39 and 48 A
vy
/a and a/a offspring, respectively) showed 
significant increases in average methylation across the CpG sites (40.6% versus 44.4% and 
42.7%, respectively; P=0.008 and 0.03, respectively) (Figure 3.3B). 
DNA methylation was significantly altered at specific CpG sites at the HsdBeta11 Type 2 
locus. In the ng exposed offspring (n=48 A
vy
/a and a/a offspring) DNA methylation was 
significantly decreased at site 4 compared to the control group (n=36 A
vy
/a and a/a offspring; 
1.06% versus 2.98%, respectively; P=0.03) (Figure 3.3C).  In the µg exposed offspring (n=21 
A
vy
/a and a/a offspring) there was a significant increase in DNA methylation at site 1) compared 
to the controls (5.29% versus 4.25%; P=0.006) (Figure 3.3C).  There were no significant 
changes in average methylation in any of the exposed offspring compared to the control 
offspring (all P>0.35) (Figure 3.3C). Additionally, there were no significant changes in average 
DNA methylation or individual CpG site at the Ppar-alpha and Ppar-gamma loci (all P>0.10) 
(Figure 3.3D and E). 
 




 Free and conjugated BPA concentrations were analyzed in a subset of PND 22 mouse 
liver samples (~1 pup per litter) from each BPA exposure and control group as well as in 51 
human fetal liver samples (Table 3.4).  Total BPA (free plus glucuronide-conjugated) 
concentrations measured in the 50 mg BPA/kg exposed mice ranged from 9.46 to 870 ng/g 
(mean=441; median=472; n=9). Total BPA in animals exposed to 50 µg BPA/kg ranged from 
below LOQ to 11.3 ng/g (mean=2.02; median=0.56; n=10). BPA concentrations in the liver from 
mice exposed to 50 ng BPA/kg ranged from below LOQ to 13.0 ng/g (mean=2.78; median=0.31; 
n=11). Total BPA in the control group ranged from below LOQ to 11.5 ng/g (mean=4.26; 
median=4.24; n=10). To compare mouse liver BPA concentrations to physiologically relevant 
doses in humans, fetal human liver tissues were also analyzed for free and glucuronide-
conjugated BPA. Total BPA concentrations in human fetal liver ranged from below LOQ to 96.8 
ng/g (mean=10.8, median=3.39; n=51). The overlap between mouse liver BPA levels and human 
fetal liver BPA levels indicates that the experimental approach employed for dietary animal 
exposure captures a relevant and full range of human BPA exposure.    
 
3.5  Discussion 
In this chapter, dose-dependent phenotypic and epigenetic responses following maternal 
dietary exposure to three levels of BPA were reported. First, a decrease in PND 22 wean body 
weight in a/a and A
vy
/a offspring exposed to 50 ng/kg diet of bisphenol A (BPA) versus control 
offspring was observed. This association persists when analysis is restricted to a/a offspring 
alone, indicating that this effect is not associated with the epigenetically-controlled adult onset 
obesity associated with A
vy
/a offspring, but rather manifests as a result of perinatal BPA 
exposure. Body weight differences were not detected in offspring exposed to either 50 µg or 50 




previous studies using multiple doses of BPA with non-linear outcomes [Honma et al., 2002; 
Rubin et al., 2001]. Non-monotonic effects of BPA on DNA methylation suggest that BPA, and 
endocrine disruptors in general, can effect different mechanisms involved in epigenetic 
regulation and should be further investigated.  
Global methylation of the mouse genome assessed using the LUMA assay reveals a 
significant increase in methylation across all BPA exposure groups in comparison to controls. 
This assay provides a measure of methylation at CCGG sites throughout the entire genome 
regardless of location, representing the degree to which the genome is globally methylated. The 
LUMA assay has been extensively employed in analysis of human cancers [Deneberg et al., 
2010; Lee et al., 2008; Poage et al., 2011]. There are limited studies, however, exploring 
environmental and/or nutritional exposures and their impact on global methylation [Gallou-
Kabani et al., 2010]. Recently, using a mouse model, Gallou-Kabani et al. [2010] associated 
maternal high fat diet with decreased placental tissue DNA methylation in female offspring . The 
global decrease in CCGG methylation was not associated with decreased methylation at LINE-1 
or B1 repetitive elements. Gene specific methylation at the Igf2r gene in female offspring 
exposed to high fat diet, on the other hand, was increased.  Thus, it is important to note that the 
LUMA assay is restricted to methylation of CCGG sequences throughout the genome and is not 
necessarily representative of physiologically-induced local changes at candidate genes or 
repetitive content derived from transposable elements such as LINE-1 and B1.  
We also note dose-dependent shifts in the coat color distribution of genetically identical 
A
vy
/a offspring exposed to a 50 mg, µg, or ng/kg diet of BPA perinatally. The coat color 
distribution of offspring exposed to a 50 mg/kg diet of BPA displays a shift towards the yellow 




µg dose offspring displays a shift towards the pseudoagouti lean coat color phenotype. Average 
methylation at the A
vy
 locus of the mg exposed offspring is significantly decreased in comparison 
to the control group, providing epigenetic validation of the coat color distribution shift. In 
contrast, average methylation at the A
vy
 locus of the µg exposure group was not statistically 
significant. An excess of categorization as slightly mottled A
vy
/a offspring may have offset a 
hypermethylation response among the µg exposure group when compared to the control group. 
Increased methylation in µg offspring compared to control offspring was, however, detected at 
the Cabp
IAP
 metastable epiallele, signifying that perinatal exposure to BPA at this dose increases 
methylation at this particular epigenetically labile locus. Taken together, these results 1) indicate 
that methylation at more than one locus is variable after perinatal exposure to BPA, 2) strengthen 
the evidence for non-monotonic dose-dependent effects of BPA, and 3) provide evidence that 
variable dose levels of BPA act across different biological pathways [Vandenberg et al., 2009].   
Further candidate gene methylation analysis in PND 22 liver tissue revealed alterations in 
DNA methylation profiles at the two imprinted genes H19 and Igf2, but not in the non-imprinted 
genes HsdBeta 11 Type 2, Ppar-alpha, and Ppar-gamma. The famine of 1944-45 from the 
German imposed food embargo during World War 2 demonstrates that exposure to malnutrition 
during conception/early gestation resulted in the development of hypomethylation of the IGF2 
differentially methylated region (DMR) in whole blood of the offspring at ~ age 60 when 
compared to unexposed same-sex siblings [Heijmans et al., 2008]. Additionally, dietary exposure 
to 50 µg and 50 mg BPA/kg of diet in mice during embryonic days 0-12.5 displayed a decrease 
in embryonic Igf2 DMR 1 methylation [Susiarjo et al., 2013]. This evidence along with our 
candidate gene analysis indicates the potential of early developmental insults to affect candidate 




wide DNA methylation to discover novel regions of altered methylation and gene expression 
following perinatal BPA exposure in light of this evidence at candidate loci.  
Due to BPA’s ubiquitous existence in the environment and the ongoing debate about 
whether human internal BPA levels pose a health concern [Ginsberg et al., 2009; Volkel et al., 
2002], it is of significance that animal studies capture human physiologically relevant exposure 
levels to determine BPA’s impact on human health outcomes.  In the present study, we aimed to 
achieve physiologically relevant levels by including a high (mg), medium (µg), and low (ng) 
dose of BPA in the maternal diet. Calafat et al. [2008] reported a range of urinary total BPA (free 
and conjugated) of 0.4 to 149 ng/mL representative of individuals 6 years of age or older (n = 
2517) in subjects measured as a part of the 2003-2004 National Health and Nutrition 
Examination Survey (NHANES). Lang et al. [2008] reported urinary total BPA levels ranging 
from 3.34 to 4.48 ng/mL in individuals aged 18 years or older who have normal BMI (n = 469) 
from the 2003-2004 NHANES . Additionally, Padmanabhan et al. [2008] measured a range of 
0.5 to 22.3 ng/mL of circulating free BPA (unconjugated) in maternal blood collected upon 
delivery.  
We report PND 22 mouse liver BPA measurements ranging from below the limit of 
quantitation (LOQ) to 870 ng/g across all exposure groups comparable to human fetal liver 
measurements ranging from below LOQ to 96.8 ng/g. Ideally, liver BPA levels would be 
measured in fetal mouse tissues and compared to human fetal tissues; however, study design and 
current analytical requirements preclude this direct comparison. Nonetheless, mouse liver total 
and free BPA levels among A
vy
/a offspring exposed to 50 mg BPA/kg diet in our study range 
from 9.46 to 870 and 2.68 to 390 ng/g, respectively, (Table 3.4) and are comparable to mouse 




d6/kg diet ad libitum for a 24 hour period [Sieli et al., 2011]. Sieli et al. [2011] show that in 
comparison to mice receiving a single oral bolus exposure of 20 mg BPA/kg body weight, 
animals fed BPA in the diet reach a maximum serum concentration of total and unconjugated 
(free) BPA at 6 hours of 802 and 18.8 ng/mL, respectively compared to 1 hour in the bolus 
group. Moreover, the observed serum concentrations following BPA administration in the diet 
are within the range of human exposure. Within the current study, we also observe a high degree 
of inter-individual variation in mouse liver BPA concentrations within a particular dose group as 
well as the controls, perhaps reflecting time and metabolism effects associated with recent 
feeding bouts and/or continued nursing of pups. Unlike single bolus ingestion or injection routes 
of exposure, dietary exposure through feed results in inherent inter-individual variability. It is 
important to note that we do not see a profound difference in mean or median mouse liver BPA 
concentrations among control and the two low dose groups; in fact, BPA is detected in some 
control animals despite housing in BPA-free caging and receiving BPA-free water. A limitation 
of this study is possible BPA cross-contamination via air given that animals were housed in a 
single room to minimize environmental heterogeneity that contributes to underlying epigenetic 
lability.  
 
3.6  Conclusion 
To our knowledge, this is the first study conducted using the viable yellow agouti 
epigenetic biosensor to analyze offspring phenotypic and epigenetic effects following multiple 
dose levels of either an environmental exposure or nutritional agent. Isogenic A
vy
 mice allow for 
reproducible experiments as seen here with the coat color shift towards yellow in the A
vy
/a 
offspring exposed to the 50 mg BPA/kg diet [Dolinoy et al., 2007]. We took a candidate gene 




associated with early life environmental perturbations, along with a global CCGG sequence 
assay. In order to conduct an unbiased epigenetic analysis, genome-wide methylation 
experiments must be applied in animal models. Epigenome-wide approaches will generate a 
template useful for the foundation and understanding of the full effect of BPA on the mouse 
epigenome. Concurrent studies are needed to assess BPA’s effect on the human epigenome, and 
whether labile loci between the mouse and human display significant overlap. In understanding 
the epigenome as a whole, one must also consider other epigenetic mechanisms such as histone 
modifications and microRNA interference separately and in conjunction with each other, and 
their sensitivity to environmental disruptions. Recently, DNA methylation and histone 
modifications have been observed to act in concert with one another at the A
vy
 metastable 
epiallele [Dolinoy et al., 2010]. Increasing studies focusing on multiple epigenetic mechanisms 
















Table 3.1 PCR primers and sequences. Primers (5’ to 3’) and sequences to analyze for DNA 
methylation quantification via pyrosequencing for candidate genes. Y in sequence to analyze signifies a 
CpG site of interest. 
 
Primer/Sequence 
to Analyze   
Avy Assay   
Forward PCR ATTTTTAGGAAAAGAGAGTAAGAAGTAAG 




CabpIAP Assay   
Forward PCR ATTATTTTTTGATTGGTTGTAGTTTATGG 




Igf2 DMR Assay   
Forward PCR TTTTTTAATATGATATTTGGAGATAGTT 




H19 Assay   
Forward PCR GGGGGGTTATAAATGTTATTAGGGGGGTAGG 




HsdBeta 11 Type 
2 Assay   
Forward PCR GGGGTGTTAAGATAGAAGTGGA  
Reverse PCR AACAACAAACCCTAACACAACCAATC  
Sequencing AGTGGAGGAAAGTTTTA  
Sequence to 
analyze TYGTTTTYGTATYGTTTTAATTTYGTTTTTAGGGYG  
Ppar-alpha Assay   
Forward PCR Qiagen primer: PM00275758 
Reverse PCR Qiagen primer: PM00275758 




Assay   
Forward PCR TGGTGTGTATTTTATTGTAATTTTAAAAAG 








Table 3.2 Global DNA methylation. LUMA methylation levels in tail DNA among A
vy
/a and 
a/a offspring  
Exposure N 
Mean percent 




control 60 51.6 (17.9) 
 
mg 71 59.3 (15.2) 0.02 
µg 52 60.3 (13.4) 0.007 


























 loci from tail DNA 
Locus N Exposure 
Mean percent 
methylation (SD) across 
CpG sites 6-9 
Mean percent 
methylation 
(SD) site 6 
Mean percent 
methylation 
(SD) site 7 
Mean percent 
methylation 
(SD) site 8 
Mean percent 
methylation 
(SD) site 9 
Avy   38 control 35.6 (26.4) 34.5 (26.4) 35.2 (23.2) 35.5 (27.2) 37.3 (30.3) 
(Avy/a offspring) 43 mg  24.3 (18.7)** 23.7 (18.9)** 24.1 (16.5)** 22.6 (18.8)** 26.7 (21.6)* 
 32 µg 35.9 (27.5) 34.2 (27.8) 34.7 (23.7) 35.4 (27.7) 39.2 (31.5) 
 48 ng 34.1 (25.2) 33.1 (25.5) 32.6 (21.9) 33.7 (25.4) 37.2 (28.8) 
CabpIAP  82 control 83.1 (8.2) 84.6 (8.1) 81.5 (8.4) 78.5 (9.7) 88.0 (9.3) 
(Avy/a  and a/a  85 mg 83.6 (6.4) 85.8 (6.4) 81.4 (6.9) 79.1 (7.1) 88.3 (7.7) 
offspring) 67 µg 85.8 (5.6)** 87.5 (5.4)** 83.3 (6.6) 81.8 (6.5)** 90.6 (6.2)** 
  107 ng 84.3 (6.0) 86.0 (5.8) 82.3 (7.2) 79.3 (7.6)** 89.6 (6.1)** 




Table 3.4 BPA liver concentrations (ng/g). Measurements from mouse PND 22 A
vy
/a offspring tissue liver and human fetal liver 
tissue ranging from gestational ages 74 to 120 
  
Mice fed mg/kg 
diet (n = 9) 
Mice fed µg/kg 
diet (n = 10) 
Mice fed ng/kg 
diet (n = 11) 
Mice fed control 
diet (n = 10) 
Human fetal 
(n = 51) 
Range Total BPA, 
ng/g 
9.5-870 <LOQ-11.3 <LOQ-13 <LOQ-11.5 <LOQ-96.8 
Mean (SD) free-
BPA, ng/g   




278 (233) 0.3 (0.3) 1.0 (1.6) 0.6 (0.8) 3.2 (8.0) 
Mean (SD) total 
BPA, ng/g  
441 (338) 2.0 (3.5) 2.8 (4.5) 4.3 (3.5) 10.8 (18.5) 
Median Total BPA, 
ng/g 
472 0.6 0.3 4.2 3.4 










 allele contains a contra-oriented IAP insertion within pseudoexon 1A (PS1A) of the 
Agouti gene. A cryptic promoter (arrowhead labeled A
vy
 ectopic) drives constitutive ectopic 
Agouti expression. Transcription of the Agouti gene normally initiates from a developmentally 
regulated hair-cycle promoter in exon 2 (arrohwhead labeled A, a wildtype). The location of the 
bisulfite-converted genomic reverse primer for amplifying the A
vy
 IAP is underlined. B) The 
Cabp
IAP
 allele contains a contra-oriented IAP insertion within intron 6 of the murine CDK5 
activator binding protein (Cabp) gene, resulting in short aberrant transcripts originating from the 
5’LTR of the IAP (arrowhead labeled Cabp AT1a,b). Aberrant transcripts also originate at the 
normal transcription start site (arrowhead labeled Cabp wildtype) and truncate 5’ of the IAP 
insertion (Cabp AT2 and AT3). Normal Cabp transcription covers 14 exons, resulting in a 2kb 
transcript. Location of the bisulfite-converted genomic reverse primer for amplifying the Cabp
IAP
 










Figure 3.2 Coat color distribution  
 
A) Coat color phenotype distribution among 50 mg/kg BPA exposed offspring (n=45) versus 
control offspring (n=38). 50 mg/kg BPA maternal intake demonstrates a shift in offspring coat 
color towards yellow (P=0.006). B) Coat color phenotype distribution among 50 µg/kg BPA 
offspring (n=32) versus control offspring.  50 µg/kg BPA maternal intake demonstrates a shift in 
coat color towards pseudoagouti (P=0.04). C) Coat color phenotype distribution among 50 ng/kg 
BPA offspring (n=48) versus control offspring. 50 ng/kg BPA maternal intake demonstrates a 






Figure 3.3 Percent methylation of candidate loci  
 
 
Average and CpG site-specific DNA methylation levels in  A) H19, B) Igf2, C) HsdBeta11 Type 2, D) Ppar-alpha, and E) Ppar-gamma in PND 
22 liver tissue of Avy/a and a/a offspring. The y-axis represents percent methylation. *indicates P<0.05 compared to control exposure 
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Novel epigenetic biomarkers mediating bisphenol A exposure and metabolic phenotypes 
 
 
4.1  Abstract 
 There is compelling evidence that epigenetic modifications link developmental 
environmental insults to disease susceptibility in adulthood. Animal studies have linked perinatal 
bisphenol A (BPA) exposure to altered DNA methylation, but these studies have been limited to 
candidate gene and global methylation approaches. Utilizing an epigenome-wide discovery 
platform, this chapter elucidates epigenetic alterations in liver tissue from adult offspring (10 
months) following perinatal BPA exposure at human physiologically relevant doses (50 ng, 50 
μg, and 50 mg BPA/kg diet).  Biological pathway analysis was run on the significant 
differentially methylated regions among females to determine which pathways were enriched, 
and whether they are involved in the metabolic or hyperactive phenotypes displayed in the BPA 
exposed offspring from the life-course phenotyping described in Chapter 2. Furthermore, 
utilizing the top enriched biological pathways, three candidate genes were chosen to assess DNA 
methylation as a mediating factor linking the association of perinatal BPA exposure to the 
metabolic phenotypes in female offspring. Of the significant differentially methylated probes, the 
biologically pathways that were enriched include insulin signaling, adipocytokine signaling, and 
tyrosine hydroxylase pathways. From these pathways, three candidate genes, Insulin Receptor 




mediational regression analysis. DNA methylation in two of the candidate genes, Irs-2 and Jak-
2, was linked as a mediator in the mechanistic pathways of BPA exposed females and the 
adiponectin and glucose phenotypes, respectively. Data generated from this study is crucial for 
deciphering the role of epigenetics in the pathogenesis of chronic disease and the development of 
novel epigenetic-based prevention and therapeutic strategies for complex human disease. 
 
 
4.2  Introduction 
The developmental origins of health and disease hypothesis (DOHaD) postulates that 
early nutritional and environmental exposures shape health outcomes throughout the life-course 
[Barker, 2004]. Bisphenol A (BPA), a chemical found in consumer products including beverage 
and food containers and thermal papers, is an environmental exposure that has been associated 
with disease development in adulthood after early-life exposure [Vandenberg et al., 2010]. BPA 
is an endocrine active compound that interferes with estrogen [Gould et al., 1998; Kuiper et al., 
1998], androgen [Kruger et al., 2008], and thyroid function [Moriyama et al., 2002] as well as 
transcription factors like peroxisome x receptor (PXR) and aryl hydrocarbon receptor (AhR) 
[Kruger et al., 2008; Sui et al., 2012]. Additionally, BPA has the ability to impair the 
development of the central nervous system resulting in behavioral disorders [Braun et al., 2011; 
Wolstenholme et al., 2011]. Thus, BPA’s influence on normal differentiation and maturation 
processes during early development, with health risk manifesting later in life, is of concern. 
When elucidating mechanisms involved in DOHaD, epigenetic pathways, such as DNA 
methylation, histone modifications and chromatin modeling, are a primary mechanism of interest 
[Gabory et al., 2011]. Of these epigenetic modifications, DNA methylation is the most widely 




established early in development, but increasing evidence reveals that environmental and 
nutritional factors can drive sustained alterations to DNA methylation when encountered early in 
development. Recently, using the viable yellow agouti (A
vy
) mouse model, our group has shown 
that maternal dietary exposure to three physiologically relevant levels of BPA (50 mg, μg, or ng 




 metastable epialleles and the Igf2, 
and H19 imprinted loci. Perinatal exposure to 50 mg BPA/kg diet resulted in decreased DNA 
methylation at the A
vy 
locus [Anderson et al., 2012; Dolinoy et al., 2007], while perinatal 
exposure to the lower doses, 50 ng and 50 μg BPA/kg diet, resulted in increased methylation at 
the Cabp
IAP
 locus [Anderson et al., 2012]. Perinatal exposure to 50 μg BPA/kg diet resulted in 
decreased DNA methylation at H19, while perinatal exposure to 50 ng and 50 mg BPA/kg diet, 
resulted in increased methylation at the Igf2 locus (Figure 3.3B). 
 Developmental exposures to BPA that have been associated with alterations in epigenetic 
modifications implicate the risk for chronic disease such as cancer, type 2 diabetes, and obesity 
as well as impaired brain development and behavior [Jirtle et al., 2007; Kundakovic et al., 2011]. 
For example, exposure to 10 µg BPA/kg BW/day in male rats during early development resulted 
in hypomethylation at the phosphodiesterase type 4 variant 4 gene in prostate cancer cells during 
adulthood [Ho et al., 2006]. In utero exposure to 5 mg/kg body weight resulted in decreased 
methylation in Hoxa10, a gene involved in several cancers like endometrial carcinoma, in adult 
female mice [Bromer et al., 2010; Yoshida et al., 2006].  Two additional genes implicated in 
prostate carcinogenesis, nucleosome binding protein-1 and hippocalcin-like 1, displayed hypo- 
and hypermethylation, respectively, in adult rats exposed to 10 µg BPA/kg body weight during 




 Most studies aimed to investigate the effects on the epigenome following environmental 
and nutritional exposures have been limited by being candidate gene driven approaches or based 
on epigenetic techniques with limited genome coverage and sensitivity. Given that the main goal 
of DOHaD research is to understand the role that early environmental insults have on health and 
disease, deep sequencing and tiling array technologies are of most value in order to elucidate key 
regulatory pathways that are involved in the etiology of disease via epigenetic mechanisms. 
Further, following animals perinatally exposed across the life-course, helps identify a role for 
early exposure and later-in-life disease risk. Thus, by utilizing an epigenome-wide platform as a 
discovery tool in combination with life-course sophisticated in vivo phenotyping, we now 
examine regions of altered methylation (RAMs) as the potential mediators on the development of 
metabolic phenotypes in adulthood after perinatal BPA exposure. 
 
 
4.3  Materials and Methods 
 
4.3.1  Mouse Liver Samples and DNA isolation 
The liver tissues utilized for this chapter include the BPA exposed and control non-agouti 
a/a wild-type offspring that were aged out to 10 months and underwent the metabolic 
phenotyping described in Chapters 1 and 2. For this study, 10 month liver DNA from a subset of 
the a/a offspring was analyzed for altered regions of methylation in murine promoter regions: 1) 
standard control diet (n=6 offspring; 3 male and 3 female); 2) 50 ng BPA/kg diet (n=6 offspring; 
3 male and 3 female); 3) 50 µg BPA/kg diet (n=5 offspring; 2 male and 3 female); 4) 50 mg 




Total genomic DNA was isolated from 10 month liver tissue (n=23) using a standard 
phenol-chloroform extraction method. Briefly, about 15 mg of tissue was resuspended in 540 µl 
buffer ATL and homogenized for 20 seconds at 15 Hz (TissueLyser, Qiagen). The lysate was 
transferred to 60 µl of Proteinase K and incubated for overnight at 50C. After overnight 
incubation 12 µl of RNase A was added to lysate and incubated for 10 minutes at 37C. Samples 
were extracted twice with 600 µl phenol–chloroform–isoamyl and once with 600 µl chloroform. 
50 µL of 3M sodium acetate was added to aqueous phase and precipitated with 1 mL ice-cold 
100% ethanol. For additional precipitation, 1 mL of ice-cold75% ethanol was added to pellet 
twice. The pellet was air dried and resuspended with 100 µl Tris-EDTA buffer and incubated for 
2 hours at 60C with frequent mixing.  
 
4.3.2  DNA Fragmentation   
Genomic DNA was sheared to fragment sizes between 200 and 1000 bp. Briefly, 17 µg 
of DNA was divided into equal volumes into 2 separate PCR tubes (8.5 ug DNA each). DNA 
was sonicated with a total process time of 15 minutes with 15 second on and 30 seconds off 
cycles at an amplitude of 18 (Episonic 1100 series, Farmingdale, NY) in 8-20C water 
(monitored and cooled every 5 minutes of process time). Fragment sizes were confirmed by gel 
electrophoresis with ~1 µg DNA.  
 
4.3.3  Enrichment of Methylated DNA 
Methylated regions of fragmented DNA were enriched by methyl-CpG binding domain-
based capture (MBD-Cap) using the Methylated DNA Enrichment Kit (Epimark, New England 




MBD2 protein, which is coupled to paramagnetic protein A beads. First, the MBD2-Fc and 
beads were combined, incubated by rotation for 15 minutes at room temperature, and washed 
twice. The fragmented DNA was then added to the MBD2-Fc/bead mixture and incubated by 
rotation for 20 minutes at room temperature and washed three times to discard unbound DNA. 
The captured methylated CpG DNA was eluted with 100 µl of DNase-free water and 15 minutes 
of incubation at 65C. 
 
4.3.4 Whole Genome Amplification, and Enrichment Quality Assessment via qPCR 
 DNA enriched for CpG methylation underwent whole genome amplification (WGA) 
according to the manufacturer’s instructions using GenomePlex Complete Whole Genome 
Amplification Kit (Sigma, St. Louis, MO). Validation and quality assurance of the enriched 
fraction was performed using a positive methylated control (Xist) and a negative unmethylated 
control (H19) loci via qPCR. Briefly, 60 ng of the genomic sonicated DNA, non-captured 
fraction from enrichment, and WGA enriched fraction were prepared as 1:10 serial dilutions. 
qPCR components were prepared using SYBR Green master mix (Qiagen Inc., Valencia, CA), 
forward primer (0.25 pmol), and reverse primer (0.25 pmol). The qPCR was performed using the 
following parameters: initial denaturation at 95°C for 3 minutes, denaturation at 95°C for 10 
seconds, annealing at 62C for 30 seconds, elongation at 72C for 10 seconds, repeated for 39 
cycles starting at the second denaturation step. All samples were run in duplicate. The cycles to 
threshold were averaged across duplicates and used to quantitate enrichment of the IP fraction 






4.3.5 Hybridization and Array Scanning 
Experimental (IP) and control (input) samples were labeled with Cy5 and Cy3, 
respectively with the NimbleGen Dual-Color DNA Labeling Kit (Roche, Indianapolis, IN) 
following the NimbleGen Arrays User Guide (NimbleGen Arrays User Guide DNA Methylation 
Arrays, Version 7.2). IP and input samples were pooled and co-hybridized to Roche NimbleGen 
Mouse DNA Methylation 3x720K CpG Island Plus RefSeq Promoter Arrays for a period of 16 to 
20 hours. After the hybridization period was complete, arrays were washed and scanned using 2- 
µm, high-resolution NimbleGen MS 200 Microarray Scanner (Dr. Thomas Glover, Department 
of Human Genetics, University of Michigan). 
 
4.3.6 Bioinformatics Pipeline  
All arrays were uploaded to NimbleGen DEVA Software (version 2.3). An alignment 
grid was laid over each subarray image in order to extract the location of each feature as well as 
to generate the raw signal intensities from the IP and input samples. The appropriate 
normalization procedure was determined by visualizing the distribution of each subarray. The 
normalization process consisted of two steps: 1) the log2 ratio of the input and IP channels were 
calculated; 2) the log2 ratios were corrected by subtracting the Tukey’s biweight estimate of the 
median. The Tukey’s biweight estimate is determined by a weight given to each data using a bi-
square weight function. The weights assigned are greater for data values near the median of the 
data cluster and decrease for data away from the median, so outliers have a minimal effect on the 
estimate [Adriaens et al., 2012]. The following statistical analyses were performed with R 
Statistical Software (version 2.10.1). An empirical Bayesian T-test was calculated to assess the 




groups (50 ng, 50 µg, or 50 mg BPA/kg diet) versus the control group. Analyses were done by 
pooling sexes as well as by stratifying by sex. Significant differentially methylated genes were 
chosen based on adjusted P-values <0.001. 
 
4.3.7 Pathway Analysis 
 The top hit genes with adjusted P-values <0.001 were read into Database for Annotation, 
Visualization and Integrated Discovery (DAVID ) (version 6.7) for identification of key 
biological pathways involved among the most differentially methylated genes. For this 
dissertation, candidate genes were chosen from enriched biological pathways that may be 
involved the metabolic or hyperactive phenotypes displayed in the BPA exposed offspring 
described in Chapter 2. The pathway analysis was limited to females since the metabolic and 
hormone phenotypes were exhibited strictly in female offspring. The three candidate genes 
chosen from the enriched biological pathways are Insulin Receptor Substrate-2 (Irs-2), Janus 
Kinas-2 (Jak-2), and Tyrosine Hydroxalase (Th). 
 
4.3.8 Mediational Regression Analysis  
Mediational regression analysis was conducted in a 4-step process to determine whether 
DNA methylation is a mediator of BPA exposure and metabolic phenotypes. First, a mixed 
effects regression analysis was performed to identify significant associations among BPA 
exposure (50 ng, 50 µg, or 50 mg BPA/kg diet) and the metabolic phenotypes (model 1) 
described in Chapter 2 (spontaneous activity, energy expenditure, body composition, and 
hormones in 9 and 10 month old offspring) in the female exposed offspring versus the control 




analyses from the empirical Bayesian T-test, described in the previous section, were utilized to 
determine the significance of the associations among BPA exposure and DNA methylation 
(model 2) in each candidate gene among the BPA exposed groups compared to the control group. 
Third, a mixed effects regression was performed to determine the associations of DNA 
methylation in each candidate gene and the metabolic phenotypes (model 3). Finally, given that 
all three previous analyses (models 1, 2, and 3) resulted in a significant relationship, a final 
mixed effects regression model measuring BPA exposure and its association on the metabolic 
phenotypes adjusting for DNA methylation was performed (model 4). Methylation was 
considered a mediator if the difference estimate resulted in a 10% attenuation in model 4 
(adjusting for methylation), compared to the model 1 (without adjusting for methylation). Due to 
the limited sample size, results were considered significant at P<0.10. All statistical analyses 
were completed using SAS software version 9.2 (Cary, NC).  
 
4.4  Results 
 
4.4.1 Identification of Differentially Methylated Regions Across BPA Exposed Offspring 
 The top and bottom 25% most differentially methylated probes indicate that there are 
clusters of genes presenting with increased and decreased methylation across all exposure groups 
compared to the controls (Figure 4.1A). Additionally, there are clusters of genes acting in a non-
monotonic fashion across exposure groups (Figure 4.1B).  
Among the 713,168 probes, about 90,000 (10%) unique probes exhibited differential 
methylation by BPA exposure given the adjusted p-value cut-off of 0.001 (Figure 4.2). Among 




controls (Figure 4.2). Among µg exposed offspring, 1.2% of the loci were identified as 
differentially methylated compared to controls (Figure 4.2).  Among mg exposed offspring, 
2.5% of the loci were identified as differentially methylated compared to controls (Figure 4.2).  
 
4.4.2 Biological Pathways Involved in Differentially Methylated Regions 
 The pathways that were enriched in female BPA exposed offspring include the insulin 
signaling, adipocytokine signaling, and tyrosine metabolism pathways. The three candidate 
genes chosen from these pathways were Insulin Receptor Substrate-2 (Irs-2), Janus Kinase-2 
(Jak-2), and Tyrosine Hydroxalase (Th) (Table 4.1). Additional enriched pathways that may be 
of interest to this project include, but are not limited to, Jak-STAT signaling pathway, MAPK 
signaling pathway, and pathways in cancer, for example (Table 4.1) 
 
4.4.3 DNA Methylation Mediating BPA Exposure and Metabolic Phenotypes 
 Due to the small sample size (n=3 female per exposure group), there were limited 
associations when performing the regression analyses of BPA exposure predicting the metabolic 
phenotypes (without methylation adjustment; model 1). The trend and the differences of model 
1, however, were similar to the initial mixed effects regression analysis performed in Chapter 2 
on the full sample sizes of each exposure group (Tables 4.2-4.12).  
After modeling adiponectin as the outcome, the differences from the control group were 
attenuated 10% in all exposure groups when adjusting for methylation at Irs-2. In model 1, the 
mg exposed female offspring displayed a significant increase in adiponectin levels (P<0.0001). 
The difference from the controls was attenuated (63%) after controlling for methylation at Irs-2 




and adiponectin levels (P=0.26). Additionally, in model 1, the µg exposed females displayed a 
significant increase in adiponectin levels (P=0.001). The difference from the controls was 
attenuated (33%) after controlling for methylation at Irs-2 in model 4 (P=0.02) (Table 4.9). 
Finally, in model 1, the ng exposed females displayed a significant increase in adiponectin levels 
(P=0.0002). Again, the difference from the controls was attenuated (15%) after controlling for 
methylation at Irs-2 in model 4 (P=0.0007) (Table 4.9). 
After modeling baseline glucose as the outcome, the differences from the control group 
were attenuated <10% in all exposure groups when adjusting for methylation at Jak-2. In model 
1, the mg exposed female offspring displayed an increase in adiponectin levels (P=0.34). The 
difference from the controls was attenuated (24%) after controlling for methylation at Jak-2 in 
model 4 (Table 4.11), indicating that methylation status at Jak-2 is a potential mediator of BPA 
exposure and adiponectin levels (P=0.51). Additionally, in model 1, the g exposed females 
displayed an increase in adiponectin levels (P=0.68). The difference from the controls was 
attenuated (52%) after controlling for methylation at Jak-2 in model 4 (P=0.86) (Table 4.11). 
Finally, in model 1, the ng exposed females displayed a marginally significant increase in 
adiponectin levels (P=0.18). The difference from the controls was attenuated (59%) after 
controlling for methylation at Jak-2 in model 4 (P=0.71) (Table 4.11). 
Methylation did not result in mediation after performing mediational regression analysis 
adjusting for DNA methylation at Th (Tables 4.2-4.12). 
 
4.5  Discussion 
 Previous work as well as epigenetic analysis done in this dissertation has shown that 




of methylation in candidate gene and global methylation assays [Anderson et al., 2012; Dolinoy 
et al., 2007; Ho et al., 2006; Susiarjo et al., 2013]. In this chapter we extend beyond the 
traditional candidate and global methylation approaches by taking on an epigenome-wide 
platform. A constellation of genomic loci in mouse promoter regions following perinatal BPA 
exposure were discovered. The discovery of novel regions of altered methylation can be utilized 
for the identification of genes involved in specific disease pathways that develop after exposure 
to an environmental insult.  
The biological pathway analysis revealed an enrichment of genes involved in hormone 
regulation, like insulin and leptin, as well as in neural signaling pathways (Table 4.1). These 
pathways support data from our metabolic phenotyping data in Chapter 2, as well as other 
previously reported data on developmental exposure to BPA and resulting adult phenotypes 
[Ben-Jonathan et al., 2009; Mizuo et al., 2004; Zhou et al., 2011]. By utilizing biological 
pathway annotation tools, researchers that employ epigenome-wide platforms have the 
opportunity to identify genomic loci that are differentially methylated in a specific disease 
pathway. For example, Sabunciyan et al. examined DNA methylation of the prefrontal cortex 
from deceased individuals known to have major depressive disorder (MDD). Biological pathway 
analysis was run on the top hit differentially methylated regions to determine which genes may 
be epigenetic susceptible in the progression of MDD [Sabunciyan et al., 2012]. Additionally, 
identification of novel epigenomic biomarkers was discovered in patients with normal, 
premalignant, and oral cavity squamous cell carcinoma tumor tissue using an epigenome-wide 
platform [Guerrero-Preston et al., 2011]. The differentially methylated genes were found to be 
associated with the pathways closely related to oncogenic transformation following pathway 




behind a large set of differentially methylated genes generated from high density epigenome-
wide platforms. 
In addition to identifying new differentially methylated genes by BPA exposure, we were 
able to combine genome-wide methylation data with previous life-course phenotyping to 
perform a meditational regression analysis to assess whether DNA methylation. The mediational 
regression analysis revealed two genes, Irs-2 and Jak-2, involved in hormone signaling as 
potential mediators of BPA exposure and the metabolic phenotypes including adiponectin and 
baseline glucose levels, respectively. Characterization of epigenetic biomarkers indicative of 
developmental BPA exposure and predictive of disease development will result in unique 
opportunities to develop disease prevention strategies and therapeutic modifications of these 
differentially methylated regions acting as mediators in individuals who may be predisposed to 
disease development or in individuals with existing disease in order to facilitate reversal of 
disease progression. Due to the plasticity of the epigenome [Waterland et al., 2003] such 
strategies may include dietary supplementation or pharmaceutical intervention [Dolinoy et al., 
2007].  
Future work for this Chapter includes conducting a technical and biological validation of 
the candidate genes using pyrosequencing technology, which will increase our statistical power 
when computing the mediational regression analysis, as all animals with in vivo life course 
phenotyping can be concluded. A limitation of epigenome-wide analyses is cost, and as such, 
only a subset of animals (23 of 79) was run on the NimbleGen array platform.  
 




Over the past decade, epigenetic technologies have evolved from once traditional 
methods using restriction enzymes or candidate genes to modern technologies allowing for 
unbiased epigenome-wide investigation across tissues and species, yet most studies aimed to 
investigate the effects on the epigenome following environmental and nutritional exposures have 
been limited by being candidate gene or global driven approaches. Since the main goal of 
DOHaD research is to understand the role that early environmental insults have on health and 
disease, deep sequencing and tiling array technologies are of most value in order to elucidate key 
regulatory pathways that are involved in the etiology of disease via epigenetic mechanisms.  
Furthermore, there is now evidence that DNA methylation may act in concert with other 
epigenetic mechanisms such as histone modifications and chromatin remodeling complexes and 

























Table 4.1 Biological pathway analysis. DAVID pathway analysis reveals insulin response, 
adipoctyokine signaling, and tyrosine metabolism pathways in BPA exposed female offspring 
 
Pathway Number of Genes P-value 
Pathways in cancer 305 1.3E-05 
MAPK signaling 250 1.7E-03 
Wnt signaling 144 8.8E-06 
Jak-STAT signaling 142 1.9E-03 
Melanoma 94 9.3E-03 
Adipocytokine signaling  62 9.2E-02 
Insulin signaling 124 8.4E-02 
Purine metabolism 142 4.0E-02 
Cell cycle 116 5.9E-02 
Long term depression 67 6.0E-02 
Neuro-active ligand receptor 234 1.2E-02 
Tyrosine metabolism 37 4.2E-02 
Basal cell carcinoma 54 6.2E-03 


















Table 4.2 Mediational regression analysis (Oxygen Consumption). DNA methylation of Irs-
2, Jak-2, and TH mediating oxygen consumption (ml/kg/hr) following perinatal BPA exposure in 
















Consumption Full Sample Size (None) 
  
0.02 
   
(VO)  
 
mg  3901 (160) 
 
152 (219) 0.48 9 
  
ug 3473 (151) 
 
-275 (212) 0.2 10 
  
ng 4525 (150) 
 
774 (212) 0.003 10 
  









   
 
(model 1) mg  
4471 (386) 
 






















Insulin Receptor Substrate-2 
  
0.006 
   
 
(model 4) mg  




















   
 
(model 4) mg  
4427 (423) 
 

























   
 
(model 4) mg  
4593 (296) 
 























*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-








Table 4.3 Mediational regression analysis (Carbon Dioxide Production). DNA methylation 
of Irs-2, Jak-2, and TH mediating carbon dioxide production (ml/kg/hr) following perinatal BPA 
















Production Full Sample Size (None) 
  
0.59 
   
(VCO) 
 
mg  3584 (182) 
 
320 (250) 0.2 9 
  
ug 3692 (168) 
 




472 (239) 0.05 10 
  









   
 
(model 1) mg  
3843 (356) 
 






















Insulin Receptor Substrate-2 
  
0.02 
   
 
(model 4) mg  




















   
 
(model 4) mg  
3797 (362) 
 

























   
 
(model 4) mg  
3682 (339) 
 






















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-








Table 4.4 Mediational regression analysis (Ambulatory Activity). DNA methylation of Irs-2, 
Jak-2, and TH mediating ambulatory activity (counts/hr) following perinatal BPA exposure in 















Ambulatory  Full Sample Size (None) 
  
0.07 
   
Activity 
 
mg  1981 (142) 
 
610 (195) 0.002 9 
  
ug 1868 (133) 
 
497 (189) 0.009 10 
  
ng 1739 (131) 
 
367 (187) 0.05 10 
  
control 1371 (134) 






   
 
(model 1) mg  
1981 (254) 
 
















   
3 
 
Insulin Receptor Substrate-2 
  
0.14 
   
 
(model 4) mg  
2956 (528) 
 












484 (328) 0.15 
3 
  
control 1017 (346) 






   
 
(model 4) mg  
1988 (280) 
 























   
 
(model 4) mg  
1846 (178) 
 

















   
3 
 
*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-









Table 4.5 Mediational regression analysis (Horizontal Activity). DNA methylation of Irs-2, 
Jak-2, and TH mediating horizontal activity (counts/hr) following perinatal BPA exposure in 














Horizontal  Full Sample Size (None) 
  
0.02 
   
Activity 
 
mg  3446 (180) 
 
856 (251) 0.007 9 
  
ug 3241 (167) 
 




476 (241) 0.05 10 
  









   
 
(model 1) mg  
3320 (362) 
 






















Insulin Receptor Substrate-2 
  
0.21 
   
 
(model 4) mg  
4577 (760) 
 

























   
 
(model 4) mg  
3381 (475) 
 

























   
 
(model 4) mg  
3128 (244) 
 






















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-









Table 4.6 Mediational regression analysis (Vertical Activity). DNA methylation of Irs-2, Jak-


















Vertical  Full Sample Size (None) 
  
0.03 
   
Activity 
 
mg  1379 (125) 
 
506 (188) 0.007 9 
  
ug 1501 (127) 
 
628 (181) 0.0005 10 
  
ng 1201 (135) 
 
328 (180) 0.07 10 
  









   
 
(model 1) mg  
1164 (407) 
 






















Insulin Receptor Substrate-2 
  
0.23 
   
 
(model 4) mg  
2458 (762) 
 

























   
 
(model 4) mg  
1171 (430) 
 























      
 
(model 4) mg  
1029 (332) 
0.63 






















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-









Table 4.7 Mediational regression analysis (Body Weight). DNA methylation of Irs-2, Jak-2, 















Weight Full Sample Size (None) 
  
0.59 
   
(BW) 
 
mg  28.9 (1.5) 
 
-3.1 (2) 0.1 9 
  
ug 30.3 (1.4) 
 
-1.8 (1.9) 0.4 10 
  
ng 28.4 (1.3) 
 
-3.7 (1.9) 0.06 10 
  









   
 
(model 1) mg  29.8 (3.1) 
 
0.27 (4.3) 0.95 3 
  
ug 31.4 (3.1) 
 
1.9 (4.3) 0.68 3 
  
ng 27.4 (3.1) 
 
-2.1 (4.1) 0.63 3 
  






Insulin Receptor Substrate-2 
  
0.64 
   
 
(model 4) mg  21.5 (8.3) 
 
-13 (13.1) 0.35 3 
  
ug 32.2 (3.1) 
 
-2.3 (5.8) 0.7 3 
  
ng 29.9 (3.9) 
 
-4.5 (4.8) 0.38 3 
  









   
 
(model 4) mg  
30.5 (2.9) 
 

























   
 
(model 4) mg  

















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-












Table 4.8 Mediational regression analysis (Body Fat). DNA methylation of Irs-2, Jak-2, and 















Body Fat Full Sample Size (None) 
  
0.76 
   
(BF) 
 
mg  4.5 (.73) 
 
-1.7 (1) 0.1 9 
  
ug 5.2 (.68) 
 
-.93 (.96) 0.33 10 
  
ng 4.4 (.67) 
 
-1.7 (.96) 0.08 10 
  









   
 
(model 1) mg  5.2 (1.8) 
 
0.87 (2.5) 0.74 3 
  
ug 6.6 (1.8) 
 
2.2 (2.5) 0.4 3 
  
ng 3.9 (1.8) 
 
 -4.7 (2.5) 0.86 3 
  






Insulin Receptor Substrate-2 
  
0.42 
   
 
(model 4) mg  




















   
 
(model 4) mg  
5.7 (1.6) 
 

























   
 
(model 4) mg  

















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-










Table 4.9 Mediational regression analysis (Adiponectin). DNA methylation of Irs-2, Jak-2, 

















Adiponectin Full Sample Size (None) 
  
0.08 
   
  
mg 47.2 (7.5) 
 
15.9 (10.2) 0.13 9 
  
ug 35.2 (6.5)  4.1 (9.4) 0.67 10 
  
ng 57.3 (7.5)  26.2 (10.2) 0.02 10 
  









   
 
(model 1) mg 45.3 (2.3)  
27.7 (3.3) <.0001 3 
  
ug 34.2 (2.3) 
 
16.6 (3.3) 0.001 3 
  
ng 38.6 (2.3) 
 
21.0 (3.3) 0.0002 3 
  






Insulin Receptor Substrate-2 
  
0.0024 
   
 
(model 4) mg 34.3 (5.3) 
 
10.1 (8.3)* 0.2632 3 
  
ug 35.3 (2.0) 
 
11.1 (3.7)* 0.0192 3 
  
ng 42.0 (2.4) 
 
17.8 (3.1)* 0.0007 3 
  









   
 
(model 4) mg  
46 (2) 
 

























   
 
(model 4) mg  

















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-










Table 4.10 Mediational regression analysis (Leptin). DNA methylation of Irs-2, Jak-2, and 















Leptin Full Sample Size (None) 
  
0.38 
   
  
mg  11.2 (3.1) 
 
-6.7 (4.3) 0.14 9 
  
ug 13.6 (2.7) 
 
-4.4 (4) 0.29 10 
  
ng 17.3 (3.2) 
 
-.65 (4.4) 0.88 10 
  









   
 
(model 1) mg  

















Insulin Receptor Substrate-2 
  
0.24 
   
 
(model 4) mg  




















   
 
(model 4) mg  
14.8 (6.1) 
 

























   
 
(model 4) mg  

















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-










Table 4.11 Mediational regression analysis (Baseline Glucose). DNA methylation of Irs-2, 

















Glucose Full Sample Size (None) 
  
0.1   
 
  
mg 97.2 (6.7) 
 
19.7 (9.3) 0.05 9 
  
ug 112.6 (5.9) 
 
4.4 (8.8) 0.62 10 
  
ng 116.6 (6.5) 
 
0.37 (9.2) 0.97 10 
  









   
 
(model 1) mg 115.6 (9.4) 
 
-13.3 (13.3) 0.34 3 
  
ug 123.3 (9.4) 
 
-5.7 (13.3) 0.68 3 
  
ng 109.7 (9.4) 
 
-19.3 (13.3) 0.18 3 
  






Insulin Receptor Substrate-2 
  
0.62 
   
 
(model 4) mg 113.1 (28) 
 
-17.4 (43.4) 0.7 
 
  
ug 123.6 (10.3) 
 
-7 (19.2) 0.72 
 
  
ng 110.5 (13) 
 
-20.1 (16) 0.25 
 
  







0.9   
  
 
(model 4) mg 114.5 (9.8) 
 
-10.1 (14.4)* 0.51 3 
  
ug 121.9 (9.9) 
 
-2.7 (14.3)* 0.86 3 
  
ng 116.6 (13.7) 
 
-8 (21)* 0.71 3 
  









   
 
(model 4) mg  
119 (10) 
 






















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-









Table 4.12 Mediational regression analysis (Baseline Insulin). DNA methylation of Irs-2, 

















Insulin Full Sample Size (None) 
  
0.13 
   
  
mg  0.45 (.029) 
 
-0.66 (0.42) 0.13 9 
  
ug 1.4 (0.27) 
 
0.34 (0.4) 0.41 10 
  
ng 1.1 (0.29) 
 
-.03 (0.42) 0.98 10 
  









   
 
(model 1) mg  0.78 (0.24) 
 
-0.23 (0.35) 0.53 3 
  
ug 1.07 (0.24) 
 
0.07 (0.35) 0.85 3 
  
ng 0.63 (0.24) 
 
-0.38 (0.35) 0.31 3 
  






Insulin Receptor Substrate-2 
  
0.12 
   
 
(model 4) mg  
-0.38 (0.54) 
 























      
 
(model 4) mg  
0.84 (0.22) 
 

























   
 
(model 4) mg  

















*represents >10% change in the difference of controls in model 1 compared to model 4 and a P-
















A) Heat map indicating clusters of regions of hypo- or hypermethylation among 50 ng, 50 µg, 
and 50 mg BPA exposure groups compared to the controls. B) Heat map indicating clusters of 
regions of hypo- or hypermethylation of 50 ng, 50 µg, 50 mg BPA exposure groups and controls 
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Figure 4.2 Characterization of genome-wide methylation in BPA-exposed offspring 
 
 
Venn diagram displaying the overlap of differentially methylated regions given the p-value cut-
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CHAPTER 5  
Conclusion 
 
5.1  Overview 
The body of evidence that poses BPA exposure as a human health threat continues to 
grow. Utilizing a murine model, the goal of this dissertation was to evaluate whether human 
physiologically relevant levels of BPA during development result in the disruption of metabolic 
homeostasis throughout the life-course, and whether these metabolic alterations are mediated by 
modifications to the epigenome. The aim of Chapter 2 was to evaluate gestational and lactational 
exposure to three physiologically relevant levels of BPA through the maternal diet on several 
metabolic phenotypes and hormones using sophisticated animal phenotyping in the offspring 
throughout their life-course. The aim of Chapter 3 was to determine whether the offspring 
exhibit modifications to the epigenome, in particular DNA methylation, after maternal dietary 
exposure to the three levels of BPA using a candidate gene and global methylation approaches in 
early life tissues (post-natal day 22 liver). The aim of Chapter 4 was to further determine whether 
the offspring exhibit modifications to DNA methylation, after perinatal exposure to the three 
levels of BPA using an epigenome-wide discovery approach in adult tissues (10 month liver). 
Furthermore, a mediational regression analysis was conducted to determine if the association of 
perinatal exposure to BPA and the metabolic phenotypes observed in the offspring in Chapter 2 





5.2 Conflicting Metabolic Data 
 The goal of Chapter 2 was to take a life-course approach in measuring metabolic and 
hormone phenotypes, incorporating sophisticated in vivo animal phenotyping in perinatally BPA 
exposed murine offspring. Human epidemiological studies examining BPA exposure and 
metabolic disorders are mostly of cross-sectional design, and thus are often limited to adult 
exposure at one time-point [Lang et al., 2008], and may be confounded by food consumption 
practices and/or body composition’s effects on contaminant metabolism. Similarly, the majority 
of in vivo rodent studies examining the effects of pre- and/or neonatal BPA exposure on similar 
metabolic phenotypes only look at one time-point in the life-course. Although this is an adequate 
starting point in determining the effects of BPA on metabolic homeostasis, these approaches may 
not necessarily identify the full effects of early life BPA exposure on different life-stages [Ryan 
et al., 2010].  
In a series of studies described herein, we determined that over the course of three time-
points (3, 6, and 9 months of age) spanning young adulthood into mature adulthood, BPA 
exposed offspring exhibited hyperactive and lean phenotypes as well as improved hormonal 
parameters (9 and 10 months of age) with phenotypes being more prominent in females. Our 
observations of hyperactivity and lean body mass differ from the majority of epidemiological 
[Trasande L, 2012; Wang et al., 2012] and animal [vom Saal et al., 2012] studies that associate 
BPA with higher body weight and increased obesity, Varying results may be confounded by 
dietary practices, including diet fat and phytoestrogen composition, as well as altered BPA 
metabolism with body composition, especially in human cohorts. The finding of hyperactivity 
following perinatal BPA exposure is of significance as new Centers for Disease Control and 




children as diagnoses rise [CDC, 2011]. The relevance of our work plays into the controversial 
debate of BPA acting as an environmental obesogen. This dissertation work shows evidence 
against BPA as an obesogen, and alternatively it reveals that BPA can influence other disease 
formation such as behavioral disorders.  
Variability across rodent studies could be attributable to several factors that differ in 
experimental design. First, diet composition is not uniform across rodent models. The 
components making up each diet, such as the fat or protein content could play a role as a 
modifier to the effects of perinatal BPA exposure. Our study diet was phytoestrogen-free and on 
a non-high-fat diet background. Second, there are several routes of exposure to BPA such as 
dietary, intraperitoneal injection, and via subcutaneous osmotic pumps, for example. We opted 
to use a maternal dietary exposure as our administration route to best represent the major route of 
human BPA exposure during early development. Third, during development there are key 
developmental periods for different organ systems and varying exposure periods of BPA across 
studies may target different developmental stages. Our BPA exposure period, gestation and 
lactation, was set up to evaluate BPA’s effect during epigenomic programming. Fourth, the 
species and strains of laboratory animals are inconsistent across experiments designed to 
evaluate the same outcomes. Genetic variability may influence the adverse outcomes, and thus, 
we need to take caution when translating health effects to human populations. Finally, metabolic 
phenotyping studies are lacking sophisticated animal phenotyping equipment and may be 
missing a comprehensive analysis of important metabolic measurements. We made use of an 
established animal phenotyping core set up with state-of-the art equipment allowing for periods 
of testing lasting for several days (Michigan Nutrition Obesity Research Center, Animal 




 The range of experimental designs in studies with a common outcome, in this case 
metabolic homeostasis, makes the interpretation of the collective results difficult. With varying 
outcomes, we must take caution when deciphering whether BPA is a threat to human health, and 
take into consideration the variability in experimental design across the animal literature as 
described above. BPA exposure during several key time-points in development may result in 
various disease outcomes later in life, making it crucial to measure the biological pathways 
involved in BPA exposure which will enable researchers to develop therapeutic or preventative 
strategies for varying disease states after exposure to environmental insults.  
  
5.3  Epigenetics as Target Mechanism 
 Epigenetic fetal programming via DNA methylation may provide a pathway for BPA 
exposure to influence disease susceptibility [Jirtle et al., 2007]. The goals of chapters 3 and 4 
were to determine if BPA exposure during early development resulted in modifications to the 
epigenome, specifically to DNA methylation. We examined these modifications by using two 
approaches including a candidate gene driven, as well as an epigenome-wide discovery platform. 
Both of these approaches illustrated that BPA exposure via the maternal diet is influential on 
offspring DNA methylation programming during early development.  
 
5.3.1 Candidate Gene and Global DNA Methylation 
 Several candidate genes including two metastable epialleles, two imprinted genes, and 
three genes chosen from the literature based on our original hypothesis that BPA would result in 
obesity related phenotypes were examined. In addition, global methylation at CCGG sites 




often observed. First, the higher dietary exposure to BPA led to hypomethylation at the A
vy
 
metastable epiallele, while lower dietary levels were less effective at hypomethylating. Second, 
the middle BPA exposure dose resulted in hypermethylation at the Cabp
IAP
 metastable epiallele, 
while the low and high BPA exposures did not result in altered methylation levels. Third, at the 
imprinted locus Igf2, the low and high BPA exposure doses resulted in hypermethylation while 
the middle dose did not have altered methylation. Lastly, at the imprinted locus H19, the middle 
BPA exposure dose led to hypomethylation while the low and high doses did not result in altered 
methylation levels. These data are significant because they (1) provide mechanistic evidence for 
previously observed non-monotonic dose-dependent effects of BPA, and (2) provide evidence 
that variable dose levels of BPA may act across different biological pathways. Global 
methylation of CCGG sites resulted in increased methylation across all BPA doses. There were 
no significant changes in DNA methylation at three of the genes (HsdBeta 11 Type2, Ppar-
alpha, Ppar-gamma) chosen from the literature.  
 The majority of studies focused on epigenetic alterations following developmental 
environmental insults are focused on candidate gene approaches. This approach is useful if you 
are interested in a specific region of the genome or a very specific disease trait. It is of 
importance to note that the mouse genome contains over 23,000 genes. Thus, when utilizing a 
candidate gene approach, it is strictly limited by its reliance on the priori knowledge about the 
physiological, biochemical, or functional aspects of all possible candidates. While the 
identification of epigenetic processes of candidate genes affected by endocrine disrupting 
hormones such as BPA has its limitations, significant progress in modern technologies allowing 
for unbiased epigenome-wide investigation across tissues and species has been developed over 





5.3.2  Epigenome-wide Discovery 
 The use of epigenome-wide discovery tools combined with biological pathway analysis 
to identify the constellation of genes undergoing BPA dose-dependent epigenetic dysregulation 
in disease pathways combined with a focused candidate gene validation also serves as a 
comprehensive approach to identifying the underlying mechanisms of BPA associated metabolic 
sequela. We used an epigenome-wide platform that included about 720,000 probes in over 
20,000 mouse promoter regions to characterize regions of altered methylation, followed by 
focused validation of altered methylation at candidate loci. About 380,000 probes exhibited 
differentially methylated regions by BPA exposure in at least one of our three comparisons (ng 
versus control; ug versus control; and mg versus control). 
 The promoter epigenome-wide platform that we utilized worked as a tool in discovering 
novel epigenetic biomarkers of perinatal BPA exposure and its role in metabolic homeostasis. 
This epigenomic tool serves as a “semi-unbiased” approach because it is limited to CpG islands 
located in promoter regions. It is important to note that epigenetic modifications to DNA 
methylation outside of promoter regions have recently been discovered to play a role in  gene 
expression [Wang, 2012]. Future work should expand to other epigenome-wide technology that 
covers all other epigenomic regions of potential interest.   
 
 5.4  Role in the Field of Public Health 
 BPA is an environmental exposure of concern because it is ubiquitous in the environment 
and is found in the majority of human populations that it is tested in. Animal models of early life 




exploring BPA exposure and health outcomes in order to discover the possible role that it has on 
different disease states. However, there are limited studies that explore the possible mechanisms 
that BPA is acting upon, and additionally, linking the mechanism to the disease state. The aim of 
this dissertation was to investigate the role of perinatal BPA exposure on metabolic homeostasis 
and DNA methylation. Lastly, DNA methylation as a mediating factor on the association of BPA 
exposure and metabolic phenotypes was further tested in order to enable clinical and public 
health practices to apply and develop epigenetically-driven therapeutic and preventative 
interventions. Two top hit candidate genes were found to play a role as possible mediators in the 
development altered hormone levels after exposure to perinatal BPA. 
The elucidation of modifications to epigenomic loci associated with metabolic 
dysregulation following human physiologically relevant levels of BPA will strengthen health risk 
assessment and shape diagnostic and therapeutic strategies for disease states such as obesity and 
other metabolic disorders. The identification of epigenetic exposure biomarkers critical in 
metabolic regulation will be useful in the recognition of at-risk individuals prior to disease onset. 
Also, unlike genetic mutations, epigenetic profiles are potentially reversible; therefore, 
epigenetic approaches for prevention and treatment, such as nutritional supplementation, may be 
developed to counteract negative epigenomic profiles. Additionally, investigating the 
interactions among micronutrients required in one-carbon metabolism and those that may 
indirectly affect their supply to maintain cycle efficiency can be implicit by integrating a 
genome-wide application. If we determine that BPA exposure results in altered methylation of 
epigenetic loci important for metabolic homeostasis or negative changes in obesity-related 




supplements (e.g. folic acid and genistein) not only during development, but also later in life can 
protect against these negative effects.  
 
5.5  Future Work 
 Although there is a continual concern of the health effects following BPA exposure, an 
increasing number of products are replacing BPA with compounds such as bisphenol F (BPF) 
and bisphenol S (BPS) [Liao et al., 2013]. Evidence already reveals that these BPA replacements 
interfere with estradiol-mediated pathways [Viñas, 2013]. Additionally, other plasticizers such as 
phthalates, that are also ubiquitous throughout the environment, have been associated with 
obesity [Meeker, 2012]. For instance, a recent in vitro experiment showed that phthalates work 
as a PPAR-gamma agonist resulting in accelerated adipogenesis [Taxvig et al., 2012]. 
Furthermore, increasing levels of urinary phthalate metabolites were positively associated with 
adiposity measured via waist circumference and decreased beta cell function in male NHANES 
(1999-2002) participants [Stahlhut et al., 2007]. The perpetual presence of endocrine disrupting 
chemicals in the environment presents the opportunity for further study designs such as 
determining the safety of replacement bisphenols (BPF and BPS, for example) as well as 
evaluating the interaction of several endocrine disrupting chemicals (EDC)s on human health 
given the notion that individuals are exposed to multiple EDCs at any given time [Talsness et al., 
2009].  
 Because the epigenome is particularly sensitive at various time-points throughout the life-
course, targeted population interventions may be efficient and cost-effective. Continued animal 
epigenomic models translated into human research will strengthen our understanding in the 




the combination of nutrition and epigenomic research holds tremendous potential not only for 
individualized health, but also for diagnostic, screening, and prevention strategies for population-
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